{"id": "srdc_BYAAAAJ", "citedby": 36094, "citedby5y": 6440, "hindex": 98, "hindex5y": 38, "i10index": 392, "i10index5y": 152, "coauthors": [], "name": "John H. Griffin", "affiliation": "Professor of Molecular & Experimental Medicine", "interests": [], "cites_per_year": {"1981": 195, "1982": 260, "1983": 345, "1984": 400, "1985": 449, "1986": 550, "1987": 560, "1988": 593, "1989": 521, "1990": 494, "1991": 533, "1992": 552, "1993": 562, "1994": 620, "1995": 794, "1996": 813, "1997": 963, "1998": 838, "1999": 941, "2000": 758, "2001": 791, "2002": 838, "2003": 922, "2004": 1032, "2005": 980, "2006": 1081, "2007": 1319, "2008": 1255, "2009": 1367, "2010": 1444, "2011": 1490, "2012": 1403, "2013": 1476, "2014": 1341, "2015": 1277, "2016": 1384, "2017": 1172, "2018": 1052, "2019": 1100, "2020": 437}, "publications": [{"bib": {"title": "Deficiency of protein C in congenital thrombotic disease.", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u5HHmVD_uO8C", "citedby": "1648"}, {"bib": {"title": "The cytoprotective protein C pathway", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:d1gkVwhDpl0C", "citedby": "784"}, {"bib": {"title": "Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qjMakFHDy7sC", "citedby": "675"}, {"bib": {"title": "Plasma protein S deficiency in familial thrombotic disease", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u-x6o8ySG0sC", "citedby": "668"}, {"bib": {"title": "Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2osOgNQ5qMEC", "citedby": "662"}, {"bib": {"title": "Endothelial and antithrombotic actions of HDL", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UeHWp8X0CEIC", "citedby": "660"}, {"bib": {"title": "Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9yKSN-GCB0IC", "citedby": "645"}, {"bib": {"title": "Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IjCSPb-OGe4C", "citedby": "522"}, {"bib": {"title": "CLINICAL PERSPECTIVE", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:koF6b02d8EEC", "citedby": "455"}, {"bib": {"title": "Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:gFrPXmx1TSsC", "citedby": "432"}, {"bib": {"title": "Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zYLM7Y9cAGgC", "citedby": "426"}, {"bib": {"title": "Activated protein C resistance caused by Arg506Gln mutation in factor Va", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Y0pCki6q_DkC", "citedby": "411"}, {"bib": {"title": "Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Tyk-4Ss8FVUC", "citedby": "400"}, {"bib": {"title": "Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII)", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eQOLeE2rZwMC", "citedby": "353"}, {"bib": {"title": "Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YsMSGLbcyi4C", "citedby": "347"}, {"bib": {"title": "Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:W7OEmFMy1HYC", "citedby": "345"}, {"bib": {"title": "Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LkGwnXOMwfcC", "citedby": "338"}, {"bib": {"title": "The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WF5omc3nYNoC", "citedby": "337"}, {"bib": {"title": "Endotoxemia and sepsis mortality reduction by non-anticoagulant\u2013activated protein C", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_FxGoFyzp5QC", "citedby": "327"}, {"bib": {"title": "Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ufrVoPGSRksC", "citedby": "287"}, {"bib": {"title": "High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Se3iqnhoufwC", "citedby": "285"}, {"bib": {"title": "Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UebtZRa9Y70C", "citedby": "283"}, {"bib": {"title": "Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:roLk4NBRz8UC", "citedby": "281"}, {"bib": {"title": "A single genetic origin for a common Caucasian risk factor for venous thrombosis", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0EnyYjriUFMC", "citedby": "274"}, {"bib": {"title": "Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MXK_kJrjxJIC", "citedby": "270"}, {"bib": {"title": "Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3fE2CSJIrl8C", "citedby": "267"}, {"bib": {"title": "Activated protein C inhibits tissue plasminogen activator\u2013induced brain hemorrhage", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4TOpqqG69KYC", "citedby": "265"}, {"bib": {"title": "Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hqOjcs7Dif8C", "citedby": "255"}, {"bib": {"title": "Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Zph67rFs4hoC", "citedby": "248"}, {"bib": {"title": "Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5nxA0vEk-isC", "citedby": "248"}, {"bib": {"title": "Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8k81kl-MbHgC", "citedby": "239"}, {"bib": {"title": "Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KlAtU1dfN6UC", "citedby": "235"}, {"bib": {"title": "Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ULOm3_A8WrAC", "citedby": "231"}, {"bib": {"title": "Direct detection of activated protein C in blood from human subjects", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_kc_bZDykSQC", "citedby": "226"}, {"bib": {"title": "Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YOwf2qJgpHMC", "citedby": "225"}, {"bib": {"title": "Protein S binds to and inhibits factor Xa", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:aqlVkmm33-oC", "citedby": "214"}, {"bib": {"title": "Activated protein C", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hFOr9nPyWt4C", "citedby": "213"}, {"bib": {"title": "Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Wp0gIr-vW9MC", "citedby": "205"}, {"bib": {"title": "Activation of Human Factor VII in Plasma and in Purified Systems: ROLES OF ACTIVATED FACTOR IX, KALLIKREIN, AND ACTIVATED FACTOR XII", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qxL8FJ1GzNcC", "citedby": "204"}, {"bib": {"title": "Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M3ejUd6NZC8C", "citedby": "202"}, {"bib": {"title": "The binding and cleavage characteristics of human Hageman factor during contact activation: A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or \u2026", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mVmsd5A6BfQC", "citedby": "198"}, {"bib": {"title": "American College of Medical Genetics consensus statement on factor V Leiden mutation testing", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4DMP91E08xMC", "citedby": "193"}, {"bib": {"title": "A factor IX-deficient mouse model for hemophilia B gene therapy", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QIV2ME_5wuYC", "citedby": "191"}, {"bib": {"title": "Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7PzlFSSx8tAC", "citedby": "191"}, {"bib": {"title": "High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HDshCWvjkbEC", "citedby": "189"}, {"bib": {"title": "Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:L8Ckcad2t8MC", "citedby": "182"}, {"bib": {"title": "The biochemistry and pathophysiology of the contact system of plasma", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9ZlFYXVOiuMC", "citedby": "180"}, {"bib": {"title": "Recent advances in the understanding of contact activation reactions", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dhFuZR0502QC", "citedby": "180"}, {"bib": {"title": "Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Tiz5es2fbqcC", "citedby": "173"}, {"bib": {"title": "Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IWHjjKOFINEC", "citedby": "173"}, {"bib": {"title": "Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hC7cP41nSMkC", "citedby": "171"}, {"bib": {"title": "Impairments of the protein C system and fibrinolysis in infection-associated stroke", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TQgYirikUcIC", "citedby": "168"}, {"bib": {"title": "Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qUcmZB5y_30C", "citedby": "167"}, {"bib": {"title": "Activated protein C variants with normal cytoprotective but reduced anticoagulant activity", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Nufq_to8ts0C", "citedby": "166"}, {"bib": {"title": "Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bEWYMUwI8FkC", "citedby": "163"}, {"bib": {"title": "Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:R3hNpaxXUhUC", "citedby": "163"}, {"bib": {"title": "Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-to-Gln mutation in the gene for factor V", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZeXyd9-uunAC", "citedby": "161"}, {"bib": {"title": "Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:k_IJM867U9cC", "citedby": "158"}, {"bib": {"title": "The thrombin paradox", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RHpTSmoSYBkC", "citedby": "153"}, {"bib": {"title": "Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:e5wmG9Sq2KIC", "citedby": "153"}, {"bib": {"title": "Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild \u2026", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mB3voiENLucC", "citedby": "147"}, {"bib": {"title": "[7] Human factor XII (Hageman factor)", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_Qo2XoVZTnwC", "citedby": "147"}, {"bib": {"title": "Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the \u2026", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j3f4tGmQtD8C", "citedby": "146"}, {"bib": {"title": "Thrombophilic factors are not the leading cause of thrombosis in Beh\u00e7et\u2019s disease", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BqipwSGYUEgC", "citedby": "142"}, {"bib": {"title": "Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NMxIlDl6LWMC", "citedby": "139"}, {"bib": {"title": "Activated protein C: biased for translation", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ri6SYOTghG4C", "citedby": "137"}, {"bib": {"title": "Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet \u2026", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4JMBOYKVnBMC", "citedby": "137"}, {"bib": {"title": "Blood\u2013spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kzcrU_BdoSEC", "citedby": "135"}, {"bib": {"title": "Cytoprotective protein C pathways and implications for stroke and neurological disorders", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:b0M2c_1WBrUC", "citedby": "133"}, {"bib": {"title": "Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:r0BpntZqJG4C", "citedby": "133"}, {"bib": {"title": "High-density lipoprotein and the risk of recurrent venous thromboembolism", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:O3NaXMp0MMsC", "citedby": "132"}, {"bib": {"title": "Plasma lipoproteins, hemostasis and thrombosis", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:iH-uZ7U-co4C", "citedby": "132"}, {"bib": {"title": "Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RGFaLdJalmkC", "citedby": "131"}, {"bib": {"title": "An alternative extrinsic pathway of human blood coagulation", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:blknAaTinKkC", "citedby": "128"}, {"bib": {"title": "Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M3NEmzRMIkIC", "citedby": "127"}, {"bib": {"title": "Binding of coagulation factor XI to washed human platelets", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:maZDTaKrznsC", "citedby": "125"}, {"bib": {"title": "Identification and quantitation of protein S in human platelets", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vV6vV6tmYwMC", "citedby": "124"}, {"bib": {"title": "Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:isC4tDSrTZIC", "citedby": "123"}, {"bib": {"title": "Inhibition and complexation of activated protein C by two major inhibitors in plasma", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JV2RwH3_ST0C", "citedby": "123"}, {"bib": {"title": "Receptors for high molecular weight kininogen on stimulated washed human platelets", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hMod-77fHWUC", "citedby": "122"}, {"bib": {"title": "Total chemical synthesis of enzymatically active human type II secretory phospholipase A2", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NaGl4SEjCO4C", "citedby": "121"}, {"bib": {"title": "Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YFjsv_pBGBYC", "citedby": "121"}, {"bib": {"title": "Cardiolipin is a normal component of human plasma lipoproteins", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RYcK_YlVTxYC", "citedby": "120"}, {"bib": {"title": "Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine506\u2192Glutamine Mutation", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GnPB-g6toBAC", "citedby": "118"}, {"bib": {"title": "Human protein C: inactivation of factors V and VIII in plasma by the activated molecule", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:70eg2SAEIzsC", "citedby": "118"}, {"bib": {"title": "Protein C anticoagulant and cytoprotective pathways", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dshw04ExmUIC", "citedby": "116"}, {"bib": {"title": "Purification and characterization of plasma protein C inhibitor", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ns9cj8rnVeAC", "citedby": "116"}, {"bib": {"title": "Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent \u2026", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZHo1McVdvXMC", "citedby": "113"}, {"bib": {"title": "Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_xSYboBqXhAC", "citedby": "108"}, {"bib": {"title": "Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pqnbT2bcN3wC", "citedby": "107"}, {"bib": {"title": "Clinical studies of protein C", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2P1L_qKh6hAC", "citedby": "107"}, {"bib": {"title": "A bleeding disorder due to deficiency of alpha 2-antiplasmin", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lSLTfruPkqcC", "citedby": "107"}, {"bib": {"title": "Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:abG-DnoFyZgC", "citedby": "106"}, {"bib": {"title": "A comparision of the abilities of plasma kallikrein, \u03b2-factor XIIa, factor XIa and urokinase to activate plasminogen", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SP6oXDckpogC", "citedby": "102"}, {"bib": {"title": "Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ldfaerwXgEUC", "citedby": "101"}, {"bib": {"title": "Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of \u2026", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u_35RYKgDlwC", "citedby": "100"}, {"bib": {"title": "Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:35N4QoGY0k4C", "citedby": "99"}, {"bib": {"title": "Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pyW8ca7W8N0C", "citedby": "98"}, {"bib": {"title": "Molecular assembly in the contact phase of the Hageman factor system", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4OULZ7Gr8RgC", "citedby": "97"}, {"bib": {"title": "Pharmacological targeting of the thrombomodulin\u2013activated protein C pathway mitigates radiation toxicity", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JoZmwDi-zQgC", "citedby": "96"}, {"bib": {"title": "Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g5m5HwL7SMYC", "citedby": "94"}, {"bib": {"title": "Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SeFeTyx0c_EC", "citedby": "94"}, {"bib": {"title": "Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HoB7MX3m0LUC", "citedby": "94"}, {"bib": {"title": "Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9vf0nzSNQJEC", "citedby": "93"}, {"bib": {"title": "Nucleotide and deduced amino acid sequences of the oxidosqualene cyclase from Candida albicans", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M05iB0D1s5AC", "citedby": "93"}, {"bib": {"title": "Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zA6iFVUQeVQC", "citedby": "93"}, {"bib": {"title": "Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:fPk4N6BV_jEC", "citedby": "93"}, {"bib": {"title": "Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cFHS6HbyZ2cC", "citedby": "90"}, {"bib": {"title": "The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yD5IFk8b50cC", "citedby": "88"}, {"bib": {"title": "Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:f2IySw72cVMC", "citedby": "88"}, {"bib": {"title": "Three-dimensional model of coagulation factor Va bound to activated protein C", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3s1wT3WcHBgC", "citedby": "87"}, {"bib": {"title": "Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:olpn-zPbct0C", "citedby": "85"}, {"bib": {"title": "Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NhqRSupF_l8C", "citedby": "85"}, {"bib": {"title": "In vivo and in vitro complexes of activated protein C with two inhibitors in baboons", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:P5F9QuxV20EC", "citedby": "85"}, {"bib": {"title": "Isolation and functional properties of the heavy and light chains of human plasma kallikrein.", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rO6llkc54NcC", "citedby": "85"}, {"bib": {"title": "Activated protein C resistance: molecular mechanisms", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:D03iK_w7-QYC", "citedby": "84"}, {"bib": {"title": "A structural model for the prostate disease marker, human prostate\u2010specific antigen", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dfsIfKJdRG4C", "citedby": "84"}, {"bib": {"title": "Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uPCvBZYD9qUC", "citedby": "84"}, {"bib": {"title": "Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CHSYGLWDkRkC", "citedby": "82"}, {"bib": {"title": "Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:a0OBvERweLwC", "citedby": "81"}, {"bib": {"title": "Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:K3LRdlH-MEoC", "citedby": "80"}, {"bib": {"title": "Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:xtRiw3GOFMkC", "citedby": "79"}, {"bib": {"title": "Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OU6Ihb5iCvQC", "citedby": "78"}, {"bib": {"title": "Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vRqMK49ujn8C", "citedby": "76"}, {"bib": {"title": "Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EUQCXRtRnyEC", "citedby": "76"}, {"bib": {"title": "Aprotinin (Trasylol) is a competitive inhibitor of activated protein C", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bFI3QPDXJZMC", "citedby": "76"}, {"bib": {"title": "Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8AbLer7MMksC", "citedby": "75"}, {"bib": {"title": "Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1sJd4Hv_s6UC", "citedby": "75"}, {"bib": {"title": "Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358.", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bnK-pcrLprsC", "citedby": "75"}, {"bib": {"title": "Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UxriW0iASnsC", "citedby": "75"}, {"bib": {"title": "Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described \u2026", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:p2g8aNsByqUC", "citedby": "74"}, {"bib": {"title": "Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a \u2026", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KxtntwgDAa4C", "citedby": "74"}, {"bib": {"title": "Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tOudhMTPpwUC", "citedby": "74"}, {"bib": {"title": "\u03b22-adrenergic receptor agonists", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ML0RJ9NH7IQC", "citedby": "73"}, {"bib": {"title": "An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vDijr-p_gm4C", "citedby": "72"}, {"bib": {"title": "Functional recovery after embolic stroke in rodents by activated protein C", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:fQNAKQ3IYiAC", "citedby": "72"}, {"bib": {"title": "Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uWQEDVKXjbEC", "citedby": "71"}, {"bib": {"title": "Generation and phenotypic analysis of protein S\u2013deficient mice", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dTyEYWd-f8wC", "citedby": "70"}, {"bib": {"title": "Thrombosis in otherwise well children with the factor V Leiden mutation", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nb7KW1ujOQ8C", "citedby": "70"}, {"bib": {"title": "Protein S confers neuronal protection during ischemic/hypoxic injury in mice", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:l7t_Zn2s7bgC", "citedby": "69"}, {"bib": {"title": "Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:B3FOqHPlNUQC", "citedby": "69"}, {"bib": {"title": "Platelet factor 4 enhances generation of activated protein C in vitro and in vivo", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eflP2zaiRacC", "citedby": "68"}, {"bib": {"title": "Multibinding inhibitors of microsomal triglyceride transferase protein", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:D_sINldO8mEC", "citedby": "68"}, {"bib": {"title": "Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u9iWguZQMMsC", "citedby": "68"}, {"bib": {"title": "Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5Ul4iDaHHb8C", "citedby": "68"}, {"bib": {"title": "Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XiSMed-E-HIC", "citedby": "68"}, {"bib": {"title": "\u03b22-adrenergic receptor agonists", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Mojj43d5GZwC", "citedby": "67"}, {"bib": {"title": "Central venous thrombosis after cardiac operations in children", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eMMeJKvmdy0C", "citedby": "67"}, {"bib": {"title": "Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eJXPG6dFmWUC", "citedby": "67"}, {"bib": {"title": "PROTEIN-S AS A COFACTOR FOR ACTIVATED PROTEIN-C IN PLASMA AND IN THE INACTIVATION OF PURIFIED FACTOR-VIII-C", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:V3AGJWp-ZtQC", "citedby": "67"}, {"bib": {"title": "Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:08ZZubdj9fEC", "citedby": "65"}, {"bib": {"title": "Identification of amino acids in the gamma-carboxylation recognition site on the propeptide of prothrombin.", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1qzjygNMrQYC", "citedby": "64"}, {"bib": {"title": "Immunoblotting studies of the molecular forms of protein C in plasma", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VOx2b1Wkg3QC", "citedby": "64"}, {"bib": {"title": "Properties of sulfatides in factor-XII-dependent contact activation", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:738O_yMBCRsC", "citedby": "64"}, {"bib": {"title": "Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4fKUyHm3Qg0C", "citedby": "63"}, {"bib": {"title": "Potent blood coagulant activity of human semen due to prostasome-bound tissue factor", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LPZeul_q3PIC", "citedby": "63"}, {"bib": {"title": "Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sSrBHYA8nusC", "citedby": "63"}, {"bib": {"title": "Binding sites for blood coagulation factor Xa and protein S involving residues 493\u2013506 in factor Va", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WbkHhVStYXYC", "citedby": "62"}, {"bib": {"title": "Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:geHnlv5EZngC", "citedby": "62"}, {"bib": {"title": "An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g3aElNc5_aQC", "citedby": "61"}, {"bib": {"title": "Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mvPsJ3kp5DgC", "citedby": "61"}, {"bib": {"title": "Protein C inhibitor is expressed in tubular cells of human kidney.", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wbdj-CoPYUoC", "citedby": "61"}, {"bib": {"title": "Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XiVPGOgt02cC", "citedby": "59"}, {"bib": {"title": "Autoactivation of human plasma prekallikrein.", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PELIpwtuRlgC", "citedby": "59"}, {"bib": {"title": "Substrate-inhibited lactate dehydrogenase. Reaction mechanism and essential role of dissociated subunits", "year": "1970"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kRWSkSYxWN8C", "citedby": "59"}, {"bib": {"title": "Conversion of a plant oxidosqualene-cycloartenol synthase to an oxidosqualene-lanosterol cyclase by random mutagenesis", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5ugPr518TE4C", "citedby": "58"}, {"bib": {"title": "Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three\u2010dimensional molecular modelling of mutations of the protease \u2026", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WqliGbK-hY8C", "citedby": "58"}, {"bib": {"title": "Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding protein.", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AXPGKjj_ei8C", "citedby": "58"}, {"bib": {"title": "Activated protein C and ischemic stroke", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HE397vMXCloC", "citedby": "57"}, {"bib": {"title": "Sphingolipids as bioactive regulators of thrombin generation", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZuybSZzF8UAC", "citedby": "57"}, {"bib": {"title": "The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tS2w5q8j5-wC", "citedby": "57"}, {"bib": {"title": "Intrinsic stability and functional properties of disulfide bond\u2010stabilized coagulation factor VIIIa variants", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SdhP9T11ey4C", "citedby": "56"}, {"bib": {"title": "Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WA5NYHcadZ8C", "citedby": "56"}, {"bib": {"title": "Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4vMrXwiscB8C", "citedby": "55"}, {"bib": {"title": "Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1yQoGdGgb4wC", "citedby": "55"}, {"bib": {"title": "Hereditary thrombophilia", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sJK75vZXtG0C", "citedby": "55"}, {"bib": {"title": "Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9pM33mqn1YgC", "citedby": "54"}, {"bib": {"title": "Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:N5tVd3kTz84C", "citedby": "54"}, {"bib": {"title": "A protein S deficient family with portal vein thrombosis", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:J-pR_7NvFogC", "citedby": "54"}, {"bib": {"title": "Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_B80troHkn4C", "citedby": "53"}, {"bib": {"title": "Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5awf1xo2G04C", "citedby": "52"}, {"bib": {"title": "Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uJ-U7cs_P_0C", "citedby": "52"}, {"bib": {"title": "Effect of hyperhomocysteinemia on protein C activation and activity", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Fu2w8maKXqMC", "citedby": "51"}, {"bib": {"title": "Studies on the effect of serine protease inhibitors on activated contact factors: Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_Re3VWB3Y0AC", "citedby": "51"}, {"bib": {"title": "3K3A\u2013activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cSdaV2aYdYsC", "citedby": "50"}, {"bib": {"title": "Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:L7CI7m0gUJcC", "citedby": "50"}, {"bib": {"title": "Protein S Protects Neurons from Excitotoxic Injury by Activating the TAM Receptor Tyro3\u2013Phosphatidylinositol 3-Kinase\u2013Akt Pathway through Its Sex Hormone-Binding Globulin-Like \u2026", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9LpHyFPp1DQC", "citedby": "50"}, {"bib": {"title": "The promise of protein C", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tzM49s52ZIMC", "citedby": "50"}, {"bib": {"title": "Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity.", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Y5dfb0dijaUC", "citedby": "50"}, {"bib": {"title": "Nuclear Magnetic Resonance Titration Curves of Histidine Ring Protons IV. THE EFFECTS OF PHOSPHATE AND SULFATE ON RIBONUCLEASE", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:t6usbXjVLHcC", "citedby": "50"}, {"bib": {"title": "Conformational Changes in Aspartate Transcarbamylase I. STUDIES OF LIGAND BINDING AND OF SUBUNIT INTERACTIONS BY CIRCULAR DICHROISM SPECTROSCOPY", "year": "1972"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JQOojiI6XY0C", "citedby": "50"}, {"bib": {"title": "Statin use and sex-specific stroke outcomes in patients with vascular disease", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8p8iYwVyaVcC", "citedby": "49"}, {"bib": {"title": "\u03b22-adrenergic receptor agonists", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BCdnXsLIVDwC", "citedby": "49"}, {"bib": {"title": "Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:q3oQSFYPqjQC", "citedby": "49"}, {"bib": {"title": "Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VL0QpB8kHFEC", "citedby": "49"}, {"bib": {"title": "Alteration of fibrin network by activated protein C", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PR6Y55bgFSsC", "citedby": "48"}, {"bib": {"title": "Cytoprotective-selective activated protein C therapy for ischaemic stroke", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:gKiMpY-AVTkC", "citedby": "47"}, {"bib": {"title": "Cardiac tamponade in the fibrinolytic era: analysis of> 100 000 patients with ST-segment elevation myocardial infarction", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SWgZeABleR0C", "citedby": "47"}, {"bib": {"title": "Control of coagulation reactions", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BwyfMAYsbu0C", "citedby": "47"}, {"bib": {"title": "Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hkOj_22Ku90C", "citedby": "47"}, {"bib": {"title": "Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uLbwQdceFCQC", "citedby": "47"}, {"bib": {"title": "NUCLEAR MAGNETIC RESONANCE STUDIES OF A RIBONUCLEASE\u2010DINUCLEOSIDE PHOSPHONATE COMPLEX AND THEIR IMPLICATIONS FOR THE MECHANISM OF THE ENZYME", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZfRJV9d4-WMC", "citedby": "47"}, {"bib": {"title": "Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:a2necdfpwlEC", "citedby": "45"}, {"bib": {"title": "Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LjlpjdlvIbIC", "citedby": "45"}, {"bib": {"title": "Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VLnqNzywnoUC", "citedby": "45"}, {"bib": {"title": "Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen \u2026", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eq2jaN3J8jMC", "citedby": "45"}, {"bib": {"title": "Interaction of human plasma kallikrein and its light chain with C. hivin. 1 inhibitor", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tkaPQYYpVKoC", "citedby": "45"}, {"bib": {"title": "Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase.", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tKAzc9rXhukC", "citedby": "44"}, {"bib": {"title": "Urate crystal-dependent cleavage of Hageman factor in human plasma and synovial fluid", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_Ybze24A_UAC", "citedby": "44"}, {"bib": {"title": "Cytoprotective activated protein C averts Nlrp3 inflammasome\u2013induced ischemia-reperfusion injury via mTORC1 inhibition", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:C-Rn0OCouf8C", "citedby": "43"}, {"bib": {"title": "Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cWzG1nlazyYC", "citedby": "43"}, {"bib": {"title": "Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:W5xh706n7nkC", "citedby": "43"}, {"bib": {"title": "Arteriovenous blood metabolomics: a readout of intra-tissue metabostasis", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pQTOvowfQioC", "citedby": "42"}, {"bib": {"title": "Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue \u2026", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:fEOibwPWpKIC", "citedby": "42"}, {"bib": {"title": "Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes \u2026", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XtJa11BXPS4C", "citedby": "42"}, {"bib": {"title": "Coagulation pathways in atherothrombosis", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XD-gHx7UXLsC", "citedby": "42"}, {"bib": {"title": "A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:evX43VCCuoAC", "citedby": "42"}, {"bib": {"title": "Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yB1At4FlUx8C", "citedby": "42"}, {"bib": {"title": "Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dQ2og3OwTAUC", "citedby": "41"}, {"bib": {"title": "Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated \u2026", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2KloaMYe4IUC", "citedby": "41"}, {"bib": {"title": "A protein S binding site on C4b-binding protein involves beta chain residues 31-45.", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7T2F9Uy0os0C", "citedby": "41"}, {"bib": {"title": "Familial protein S deficiency with a variant protein S molecule in plasma and platelets", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-_dYPAW6P2MC", "citedby": "41"}, {"bib": {"title": "Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:z_wVstp3MssC", "citedby": "41"}, {"bib": {"title": "Conformational changes in aspartate transcarbamylase II. Circular dichroism evidence for the involvement of metal ions in allosteric interactions", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NJ774b8OgUMC", "citedby": "41"}, {"bib": {"title": "\u03b22-adrenergic receptor agonists", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yZoBfgUKqwcC", "citedby": "40"}, {"bib": {"title": "Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0KyAp5RtaNEC", "citedby": "40"}, {"bib": {"title": "Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:t7zJ5fGR-2UC", "citedby": "39"}, {"bib": {"title": "Binding site for blood coagulation factor Xa involving residues 311\u2013325 in factor Va", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ye4kPcJQO24C", "citedby": "39"}, {"bib": {"title": "Cytoprotective-Selective Activated Protein C Attenuates Pseudomonas aeruginosa\u2013Induced Lung Injury in Mice", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EkHepimYqZsC", "citedby": "38"}, {"bib": {"title": "Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BUYA1_V_uYcC", "citedby": "38"}, {"bib": {"title": "EFFECTS OF PLASMA KALLIKREIN AND PLASMIN ON THE 1ST COMPLEMENT COMPONENT", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nrtMV_XWKgEC", "citedby": "38"}, {"bib": {"title": "EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:otzGkya1bYkC", "citedby": "37"}, {"bib": {"title": "Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:P7Ujq4OLJYoC", "citedby": "37"}, {"bib": {"title": "Disulfide bond\u2010stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UHK10RUVsp4C", "citedby": "37"}, {"bib": {"title": "Cardiolipin enhances protein C pathway anticoagulant activity", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uc_IGeMz5qoC", "citedby": "37"}, {"bib": {"title": "Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ipzZ9siozwsC", "citedby": "36"}, {"bib": {"title": "C-terminal residues 621\u2013635 of protein S are essential for binding to factor Va", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TIZ-Mc8IlK0C", "citedby": "36"}, {"bib": {"title": "Cardiopulmonary bypass and activation of antithrombotic plasma protein C", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zLWjf1WUPmwC", "citedby": "36"}, {"bib": {"title": "Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala\u2010activated protein C mediated by factor Va", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:35r97b3x0nAC", "citedby": "36"}, {"bib": {"title": "Brain-specific protein C activation during carotid artery occlusion in humans", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MLfJN-KU85MC", "citedby": "35"}, {"bib": {"title": "Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9c2xU6iGI7YC", "citedby": "35"}, {"bib": {"title": "Complex Formation between Bovine Neurophysin-I and Oxytocin, Vasopressin, and Tripeptide Analogs of Their NH2-terminal Region ABSORBANCE AND CIRCULAR DICHROISM DIFFERENCE \u2026", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j8SEvjWlNXcC", "citedby": "35"}, {"bib": {"title": "Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ODE9OILHJdcC", "citedby": "34"}, {"bib": {"title": "Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:p__nRnzSRKYC", "citedby": "34"}, {"bib": {"title": "Complexes of activated protein C with \u03b11-antitrypsin in normal pregnancy and in severe preeclampsia", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:epqYDVWIO7EC", "citedby": "34"}, {"bib": {"title": "PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VnuxuLaQPLMC", "citedby": "33"}, {"bib": {"title": "Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EYYDruWGBe4C", "citedby": "33"}, {"bib": {"title": "Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ILKRHgRFtOwC", "citedby": "33"}, {"bib": {"title": "Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9Nmd_mFXekcC", "citedby": "32"}, {"bib": {"title": "Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4MWp96NkSFoC", "citedby": "32"}, {"bib": {"title": "Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rmuvC79q63oC", "citedby": "31"}, {"bib": {"title": "The active site of staphylococcal nuclease: paramagnetic relaxation of bound nucleotide inhibitor nuclei by lanthanide ions", "year": "1974"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AvfA0Oy_GE0C", "citedby": "31"}, {"bib": {"title": "2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: thrombotic stroke: neuroprotective therapy by recombinant-activated protein C", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eFf2swCANGcC", "citedby": "30"}, {"bib": {"title": "Generation of activated protein C during thrombolysis", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LI9QrySNdTsC", "citedby": "30"}, {"bib": {"title": "Initiation of coagulation and relationships between intrinsic and extrinsic coagulation pathways", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oNZyr7d5Mn4C", "citedby": "30"}, {"bib": {"title": "Quantitative immunoblotting of plasma and platelet protein S", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:e_rmSamDkqQC", "citedby": "30"}, {"bib": {"title": "Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:anf4URPfarAC", "citedby": "29"}, {"bib": {"title": "Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Z5m8FVwuT1cC", "citedby": "29"}, {"bib": {"title": "Plasma protein S deficiency and thromboembolic disease", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M7yex6snE4oC", "citedby": "29"}, {"bib": {"title": "Surface\u2010dependent activation of human factor XII (Hageman factor) by Kallikrein and its light chain", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uWiczbcajpAC", "citedby": "29"}, {"bib": {"title": "Studies on human protein C inhibitor in normal and factor V/VIII deficient plasmas", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hMsQuOkrut0C", "citedby": "29"}, {"bib": {"title": "Species\u2010dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:86PQX7AUzd4C", "citedby": "28"}, {"bib": {"title": "Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human-and bovine-activated protein C with negatively charged phospholipid vesicles", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0N-VGjzr574C", "citedby": "28"}, {"bib": {"title": "Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor deficiency associated with thrombosis", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ClCfbGk0d_YC", "citedby": "28"}, {"bib": {"title": "Decreased plasma levels of protein S in well-controlled type I diabetes mellitus", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kuK5TVdYjLIC", "citedby": "28"}, {"bib": {"title": "Circulating inhibitors of blood coagulation associated with procainamide\u2010induced lupus erythematosus", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KUbvn5osdkgC", "citedby": "28"}, {"bib": {"title": "Final results of the RHAPSODY trial: a multi\u2010center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A\u2010APC, a recombinant \u2026", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1xBWf43XMUgC", "citedby": "27"}, {"bib": {"title": "Novel therapeutic agents that modulate enzymatic processes", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ce2CqMG-AY4C", "citedby": "27"}, {"bib": {"title": "Multibinding inhibitors of microsomal triglyceride transferase protein", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4hFrxpcac9AC", "citedby": "27"}, {"bib": {"title": "Assay methods for detecting serum proteases, particularly activated protein C", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WZBGuue-350C", "citedby": "27"}, {"bib": {"title": "Protein S, an antithrombotic factor, is synthesized and released by neural tumor cells", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:b1wdh0AR-JQC", "citedby": "27"}, {"bib": {"title": "Human protein C and thromboembolic disease", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j2GSQqY3pL0C", "citedby": "27"}, {"bib": {"title": "Prothrombin residues 473\u2013487 contribute to factor Va binding in the prothrombinase complex", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:URolC5Kub84C", "citedby": "26"}, {"bib": {"title": "Novel therapeutic agents for membrane transporters", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tuHXwOkdijsC", "citedby": "26"}, {"bib": {"title": "Activated Protein C-Dependent and\u2013Independent Anticoagulant Activities of Protein S Have Different Structural Requirements", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mlAyqtXpCwEC", "citedby": "26"}, {"bib": {"title": "Multibinding inhibitors of cyclooxygenase-2", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tYavs44e6CUC", "citedby": "26"}, {"bib": {"title": "Interactions and inhibition of blood coagulation factor Va involving residues 311\u2013325 of activated protein C", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-FonjvnnhkoC", "citedby": "26"}, {"bib": {"title": "Activated protein C, protease activated receptor 1, and neuroprotection", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hKjooKYXoHIC", "citedby": "25"}, {"bib": {"title": "Identification of new inhibitors of protein kinase R guided by statistical modeling", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u-coK7KVo8oC", "citedby": "25"}, {"bib": {"title": "Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:FPJr55Dyh1AC", "citedby": "25"}, {"bib": {"title": "Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IUKN3-7HHlwC", "citedby": "25"}, {"bib": {"title": "Methods for identifying novel multimeric agents that modulate receptors", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rTD5ala9j4wC", "citedby": "25"}, {"bib": {"title": "Human prekallikrein (plasminogen proactivator): purification, characterization and activation by activated factor XII", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Dip1O2bNi0gC", "citedby": "25"}, {"bib": {"title": "Targeting anticoagulant protein S to improve hemostasis in hemophilia", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ojlX30-wUrgC", "citedby": "24"}, {"bib": {"title": "Apolipoprotein E Receptor 2 Mediates Activated Protein C\u2013Induced Endothelial Akt Activation and Endothelial Barrier Stabilization", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:q0uBw5dMOAkC", "citedby": "24"}, {"bib": {"title": "Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OR75R8vi5nAC", "citedby": "24"}, {"bib": {"title": "Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YohjEiUPhakC", "citedby": "24"}, {"bib": {"title": "Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SpbeaW3--B0C", "citedby": "24"}, {"bib": {"title": "Sodium channel drugs and uses", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:umqufdRvDiIC", "citedby": "24"}, {"bib": {"title": "Method for diagnosis of thrombotic disorders", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:k8Z6L05lTy4C", "citedby": "24"}, {"bib": {"title": "Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:gsN89kCJA0AC", "citedby": "24"}, {"bib": {"title": "Inhibition of arterial thrombotic occlusion or thromboembolism", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lmc2jWPfTJgC", "citedby": "24"}, {"bib": {"title": "Carbamyl Phosphate Binding to Aspartate Transcarbamylase PARTIAL SATURATION AND ITS ALTERATION BY SUCCINATE", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VaXvl8Fpj5cC", "citedby": "24"}, {"bib": {"title": "Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VN7nJs4JPk0C", "citedby": "23"}, {"bib": {"title": "Improved hemostasis in hemophilia mice by means of an engineered factor V a mutant", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vDZJ-YLwNdEC", "citedby": "23"}, {"bib": {"title": "Calcium channel drugs and uses", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KbBQZpvPDL4C", "citedby": "23"}, {"bib": {"title": "Sodium channel drugs and uses", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:i2xiXl-TujoC", "citedby": "23"}, {"bib": {"title": "Protein C pathway impairment in nonsymptomatic cigarette smokers", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:xtoqd-5pKcoC", "citedby": "23"}, {"bib": {"title": "The carbohydrate moiety of factor V modulates inactivation by activated protein C", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PVjk1bu6vJQC", "citedby": "23"}, {"bib": {"title": "Analysis of protein S C4b-binding protein interactions by homology modeling and inhibitory antibodies", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PoWvk5oyLR8C", "citedby": "23"}, {"bib": {"title": "Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative \u2026", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OTTXONDVkokC", "citedby": "23"}, {"bib": {"title": "MOLECULAR MECHANISM OF SURFACE-DEPENDENT ACTIVATION OF HAGEMAN FACTOR (HF)(COAGULATION FACTOR-XII)", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kz9GbA2Ns4gC", "citedby": "23"}, {"bib": {"title": "Interactions of Bovine Neurophysin II with Oxytocin and [8-Lysine] Vasopressin HIGH RESOLUTION PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY STUDIES", "year": "1974"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sNmaIFBj_lkC", "citedby": "23"}, {"bib": {"title": "Hormonal interactions at the molecular level: A high resolution proton magnetic resonance study of bovine neurophysins and their interactions with oxytocin", "year": "1972"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5qfkUJPXOUwC", "citedby": "23"}, {"bib": {"title": "Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UmS_249rOGwC", "citedby": "22"}, {"bib": {"title": "Species-specific anticoagulant and mitogenic activities of murine protein S", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HIFyuExEbWQC", "citedby": "22"}, {"bib": {"title": "Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ug5p-4gJ2f0C", "citedby": "22"}, {"bib": {"title": "Involvement of amino acid residues 423\u2013429 of human protein S in binding to C4b-binding protein", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:S16KYo8Pm5AC", "citedby": "22"}, {"bib": {"title": "Method for diagnosis of thrombotic disorders", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:foquWX3nUaYC", "citedby": "22"}, {"bib": {"title": "Activated protein C promotes neuroprotection: mechanisms and translation to the clinic", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hfzGNhXhx5MC", "citedby": "21"}, {"bib": {"title": "Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4n0clTBhZ78C", "citedby": "21"}, {"bib": {"title": "Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IRz6iEL74y4C", "citedby": "21"}, {"bib": {"title": "Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:edDO8Oi4QzsC", "citedby": "21"}, {"bib": {"title": "Dextran sulfate-dependent fibrinolysis in whole human plasma: Dependence on factor XII and prekallikrein", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XoXfffV-tXoC", "citedby": "21"}, {"bib": {"title": "Alternative pathways of thromboplastin-dependent activation of human factor X in plasma.", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NXb4pA-qfm4C", "citedby": "21"}, {"bib": {"title": "Assignment of an exchangeable low-field nitrogen-hydrogen proton resonance of ribonuclease A to the active-site hisitidine-119", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7VEv-pLvLSsC", "citedby": "21"}, {"bib": {"title": "Multivalent macrolide antibiotics", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:q3CdL3IzO_QC", "citedby": "20"}, {"bib": {"title": "Resistance to activated protein C: a common inherited cause of venous thrombosis", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kh2fBNsKQNwC", "citedby": "20"}, {"bib": {"title": "Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8d8msizDQcsC", "citedby": "20"}, {"bib": {"title": "STUDIES OF BOVINE NEUROPHYSIN\u2010NEUROHYPOPHYSEAL HORMONE INTERACTIONS", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ruyezt5ZtCIC", "citedby": "20"}, {"bib": {"title": "Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:G36d5HCDkJYC", "citedby": "19"}, {"bib": {"title": "Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QyXJ3EUuO1IC", "citedby": "19"}, {"bib": {"title": "Activation of protein C and hemodynamic recovery after coronary artery bypass surgery", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2VqYfGB8ITEC", "citedby": "19"}, {"bib": {"title": "Multivalent polymyxin antibiotics", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_axFR9aDTf0C", "citedby": "19"}, {"bib": {"title": "Activated protein C and inflammation in human myocardium after heart surgery", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:a9-T7VOCCH8C", "citedby": "19"}, {"bib": {"title": "Genetic mutations in ten unrelated American patients with symptomatic type 1 protein C deficiency.", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:FAceZFleit8C", "citedby": "19"}, {"bib": {"title": "Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ehil0879vHcC", "citedby": "19"}, {"bib": {"title": "Anticoagulant action of human protein C", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GtLg2Ama23sC", "citedby": "19"}, {"bib": {"title": "Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bz8QjSJIRt4C", "citedby": "19"}, {"bib": {"title": "Rabbit blood coagulation factor XI. Purification and properties", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HbR8gkJAVGIC", "citedby": "19"}, {"bib": {"title": "Factor Va increases the affinity of factor Xa for prothrombin: a binding study using a novel photoactivable thiol-specific fluorescent probe", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hCrLmN-GePgC", "citedby": "18"}, {"bib": {"title": "Multibinding inhibitors of HMG-CoA reductase", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mNrWkgRL2YcC", "citedby": "18"}, {"bib": {"title": "Upregulation of the antithrombotic protein C pathway at birth", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6ZxmRoH8BuwC", "citedby": "18"}, {"bib": {"title": "Inhibition of 2, 3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HtEfBTGE9r8C", "citedby": "18"}, {"bib": {"title": "Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LO7wyVUgiFcC", "citedby": "18"}, {"bib": {"title": "Comparative modeling of the three CP modules of the \u00df-chain of C4BP and evaluation of potential sites of interaction with protein S", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DUooU5lO8OsC", "citedby": "18"}, {"bib": {"title": "A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0izLItjtcgwC", "citedby": "18"}, {"bib": {"title": "The effect of tryptase from human mast cells on human prekallikrein", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_FM0Bhl9EiAC", "citedby": "18"}, {"bib": {"title": "Interactions of bovine neurophysins with neurohypophyseal hormones. On the role of tyrosine-49.", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:F9fV5C73w3QC", "citedby": "18"}, {"bib": {"title": "A novel ELISA for mouse activated protein C in plasma", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QYdC8u9Cj1oC", "citedby": "17"}, {"bib": {"title": "Chemical synthesis of human protein S thrombin\u2010sensitive module and first epidermal growth factor module", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XvxMoLDsR5gC", "citedby": "17"}, {"bib": {"title": "Competition of activated protein C and urokinase for a heparin-dependent inhibitor.", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:fFSKOagxvKUC", "citedby": "17"}, {"bib": {"title": "Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_5tno0g5mFcC", "citedby": "17"}, {"bib": {"title": "Carbon\u201013 nuclear magnetic resonance studies on (85% 13C\u2010enriched Gly9) oxytocin", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3htObqc8RwsC", "citedby": "17"}, {"bib": {"title": "Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zCSUwVk65WsC", "citedby": "16"}, {"bib": {"title": "Elevated plasma fibronectin levels associated with venous thromboembolism", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nZcligLrVowC", "citedby": "16"}, {"bib": {"title": "H1\u2014histamine receptor antagonists", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yqoGN6RLRZoC", "citedby": "16"}, {"bib": {"title": "Analgesic agents", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5MTHONV0fEkC", "citedby": "16"}, {"bib": {"title": "Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yMeIxYmEMEAC", "citedby": "16"}, {"bib": {"title": "Factor V Leiden and thrombophilia.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:T8_be82Iz5gC", "citedby": "16"}, {"bib": {"title": "Novel antibacterial agents", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eO3_k5sD8BwC", "citedby": "15"}, {"bib": {"title": "Stabilized proteins with engineered disulfide bonds", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nRpfm8aw39MC", "citedby": "15"}, {"bib": {"title": "Activated protein C reduces graft neutrophil activation in clinical renal transplantation", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LhH-TYMQEocC", "citedby": "15"}, {"bib": {"title": "Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dBIO0h50nwkC", "citedby": "15"}, {"bib": {"title": "Activated protein C correlates inversely with thrombin levels in resting healthy individuals", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:r_AWSJRzSzQC", "citedby": "15"}, {"bib": {"title": "Characterization of a cDNA for rhesus monkey protein C inhibitor\u2013evidence for N-terminal involvement in heparin stimulation", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:a3BOlSfXSfwC", "citedby": "15"}, {"bib": {"title": "Platelet-coagulant protein interactions in contact activation.", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:gVv57TyPmFsC", "citedby": "15"}, {"bib": {"title": "Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mUJArPsKIAAC", "citedby": "14"}, {"bib": {"title": "Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LPtt_HFRSbwC", "citedby": "14"}, {"bib": {"title": "The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_OXeSy2IsFwC", "citedby": "14"}, {"bib": {"title": "Novel therapeutic agents for macromolecular structures", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:FiytvqdAVhgC", "citedby": "14"}, {"bib": {"title": "Effect of activated protein C on the fibrinolytic components released by cultured bovine aortic endothelial cells", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WJVC3Jt7v1AC", "citedby": "14"}, {"bib": {"title": "Diagnostic Efficacy of Six Plasma Proteins in Evaluating Consumptive Coagulopathies: Use of Receiver Operating Characteristic Curves to Compare Antithrombin III, Plasminogen \u2026", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GFxP56DSvIMC", "citedby": "14"}, {"bib": {"title": "Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema.", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OP4eGU-M3BUC", "citedby": "14"}, {"bib": {"title": "13-C nuclear magnetic resonance studies of the binding of selectively 13C -enriched oxytocins to the neurohypophyseal protein, bovine neurophysin II", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HeT0ZceujKMC", "citedby": "14"}, {"bib": {"title": "Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:fbc8zXXH2BUC", "citedby": "13"}, {"bib": {"title": "Derivatives of glycopeptide antibacterial agents", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2tRrZ1ZAMYUC", "citedby": "13"}, {"bib": {"title": "Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4fGpz3EwCPoC", "citedby": "13"}, {"bib": {"title": "A Initiation mechanisms: The contact activation system in plasma", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DJbcl8HfkQkC", "citedby": "13"}, {"bib": {"title": "CLEAVAGE OF HAGEMAN-FACTOR (HF) BY A BASOPHIL KALLIKREIN OF ANAPHYLAXIS (BK-A)", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HtS1dXgVpQUC", "citedby": "13"}, {"bib": {"title": "3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GtqhT-R7ZnwC", "citedby": "12"}, {"bib": {"title": "Re-evaluation of the anticoagulant properties of high-density lipoprotein\u2014brief report", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jFemdcug13IC", "citedby": "12"}, {"bib": {"title": "Activation of protein C during reperfusion in clinical liver transplantation", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OcBU2YAGkTUC", "citedby": "12"}, {"bib": {"title": "Method for diagnosis of thrombotic disorders", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZzlSgRqYykMC", "citedby": "12"}, {"bib": {"title": "Functional assays for protein C activity and protein C inhibitor activity in plasma", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yFnVuubrUp4C", "citedby": "12"}, {"bib": {"title": "Activation of Purified C1, The First Complement Component, by Purified Plasma Kallikrein and Plasmin", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pxXbYLTb8EgC", "citedby": "12"}, {"bib": {"title": "Neuroprotective activity of activated protein c independent of its anticoagulant activity", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kVjdVfd2voEC", "citedby": "11"}, {"bib": {"title": "Multivalent macrolide antibiotics", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:aIdbFUkbNIkC", "citedby": "11"}, {"bib": {"title": "Plasma cholesteryl ester transfer protein and blood coagulability", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LgRImbQfgY4C", "citedby": "11"}, {"bib": {"title": "Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5icHVeHT4IsC", "citedby": "11"}, {"bib": {"title": "Protein kinase inhibitors", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Nnq8S6OXqDYC", "citedby": "11"}, {"bib": {"title": "Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8xutWZnSdmoC", "citedby": "11"}, {"bib": {"title": "A two-allele polymorphism in protein C inhibitor with varying frequencies in different ethnic populations", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sJsF-0ZLhtgC", "citedby": "11"}, {"bib": {"title": "Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lvd772isFD0C", "citedby": "11"}, {"bib": {"title": "THE RANGE OF GENOTYPES UNDERLYING HUMAN PROTEIN-C DEFICIENCY", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6yz0xqPARnAC", "citedby": "11"}, {"bib": {"title": "DEXTRAN SULFATE STIMULATED FIBRINOLYTIC-ACTIVITY IN WHOLE HUMAN-PLASMA-DEPENDENCE ON THE CONTACT ACTIVATION SYSTEM AND ON A UROKINASE-RELATED ANTIGEN", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GUYAmugLYisC", "citedby": "11"}, {"bib": {"title": "Elevated serum amyloid A is associated with venous thromboembolism", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hSRAE-fF4OAC", "citedby": "10"}, {"bib": {"title": "Oral anticoagulation reduces activated protein C less than protein C and other vitamin K\u2013dependent clotting factors", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Bg7qf7VwUHIC", "citedby": "10"}, {"bib": {"title": "Circulating Activated Protein C inSubjects with Heterozygous Gln506-Factor V", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uDGL6kOW6j0C", "citedby": "10"}, {"bib": {"title": "Initiation of contact activation by sulfatides.", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:F1b5ZUV5XREC", "citedby": "10"}, {"bib": {"title": "Rabbit blood coagulation factor XI. Mechanism of activation by rabbit Hageman factor (factor XII)", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NyGDZy8z5eUC", "citedby": "10"}, {"bib": {"title": "Plasma-proteins necessary for cleavage of human Hageman-factor during surface activation", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0CzhzZyukY4C", "citedby": "10"}, {"bib": {"title": "Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1EqfMoDn7-AC", "citedby": "9"}, {"bib": {"title": "The TLR4\u2010PAR1 axis regulates bone marrow mesenchymal stromal cell survival and therapeutic capacity in experimental bacterial pneumonia", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zzCxg_vo7cAC", "citedby": "9"}, {"bib": {"title": "Safety, Stability and Pharmacokinetic Properties of superFactor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2ywjKiB__4kC", "citedby": "9"}, {"bib": {"title": "Elevated CETP lipid transfer activity is associated with the risk of venous thromboembolism", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3MwzVuqRcA0C", "citedby": "9"}, {"bib": {"title": "Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OBSaB-F7qqsC", "citedby": "9"}, {"bib": {"title": "Association of Apo (a) isoform size with dyslipoproteinemia in male Venous Thrombosis patients", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PYBJJbyH-FwC", "citedby": "9"}, {"bib": {"title": "Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:43bX7VzcjpAC", "citedby": "9"}, {"bib": {"title": "Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4xDN1ZYqzskC", "citedby": "9"}, {"bib": {"title": "Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tH6gc1N1XXoC", "citedby": "9"}, {"bib": {"title": "Activated protein C resistance: What have we learned now that the dust has settled?", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:buQ7SEKw-1sC", "citedby": "9"}, {"bib": {"title": "HEREDITARY THROMBOPHILIA AS A MULTIGENIC DISEASE-INCREASED THROMBOTIC RISK DUE TO COMBINED HEREDITARY HETEROZYGOUS PROTEIN-C DEFICIENCY AND ACTIVATED PROTEIN-C RESISTANCE", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AHdEip9mkN0C", "citedby": "9"}, {"bib": {"title": "Inhibition of arterial thrombotic occlusion or thromboembolism", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nVrZBo8bIpAC", "citedby": "9"}, {"bib": {"title": "Exonic polymorphisms in the protein C gene: interethnic comparison between Caucasians and Asians", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ubry08Y2EpUC", "citedby": "9"}, {"bib": {"title": "Evolution of sterol and triterpene cyclases", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Q3-QASNKTMEC", "citedby": "9"}, {"bib": {"title": "The biochemistry of protein S", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PZE8UkGerEcC", "citedby": "9"}, {"bib": {"title": "Sulfatide bilayers as a surface for contact activation in human plasma", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:artPoR2Yc-kC", "citedby": "9"}, {"bib": {"title": "New hypothesis for the molecular mechanism of surface-dependent activation of Hageman factor (factor XII)", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jL-93Qbq4QoC", "citedby": "9"}, {"bib": {"title": "Circular dichroism and absorbance properties of nitrotyrosyl chromophores in staphylococcal nuclease and in a model diketopiperazine.", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QD3KBmkZPeQC", "citedby": "9"}, {"bib": {"title": "Design of a DNA-programmed plasminogen activator", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cdwqcPQS8ssC", "citedby": "8"}, {"bib": {"title": "An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HhcuHIWmDEUC", "citedby": "8"}, {"bib": {"title": "Plasma protein S residues 37\u201350 mediate its binding to factor Va and inhibition of blood coagulation", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NDuN12AVoxsC", "citedby": "8"}, {"bib": {"title": "Incorporation of disulfide containing protein modules into multivalent antigenic conjugates: generation of antibodies against the thrombin-sensitive region of murine protein S", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jU7OWUQzBzMC", "citedby": "8"}, {"bib": {"title": "Infrared fluorescence for vascular barrier breach in vivo\u2013a novel method for quantitation of albumin efflux", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DBa1UEJaJKAC", "citedby": "8"}, {"bib": {"title": "Protein c for use in maintaining hemostasis", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-DxkuPiZhfEC", "citedby": "8"}, {"bib": {"title": "Factor Va residues 311\u2013325 represent an activated protein C binding region", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ak0FvsSvgGUC", "citedby": "8"}, {"bib": {"title": "Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BzfGm06jWhQC", "citedby": "8"}, {"bib": {"title": "Causes of thrombophilia yet to be discovered: a personal view", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1lhNe0rCu4AC", "citedby": "8"}, {"bib": {"title": "CLEAVAGE OF HIGH-MOLECULAR-WEIGHT KININOGEN (HMWK) IN PLASMA DURING ATTACKS OF ANGIOEDEMA IN HEREDITARY ANGIOEDEMA (HAE)", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PVgj2kMGcgYC", "citedby": "8"}, {"bib": {"title": "Studies of the Activation of Human Factor X in Plasma.", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TiIbgCYny7sC", "citedby": "8"}, {"bib": {"title": "Selectively enriched carbon-13-labeled proline-7 and carbon-13-labeled leucine-8 ocytocins as probes for the analysis of peptide hormone interactions with bovine neurophysin I \u2026", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BJbdYPG6LGMC", "citedby": "8"}, {"bib": {"title": "\u03b12-macroglobulin is a significant in vivo inhibitor of activated protein C and low APC: \u03b12M levels are associated with venous thromboembolism", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kO05sadLmrgC", "citedby": "7"}, {"bib": {"title": "Novel antibacterial agents", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BPS1z4jHU5cC", "citedby": "7"}, {"bib": {"title": "Novel antibacterial agents", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mVC4hKzE2FoC", "citedby": "7"}, {"bib": {"title": "Mechanisms for Mortality Reduction by Activated Protein C in Severe Sepsis.", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lgwcVrK6X84C", "citedby": "7"}, {"bib": {"title": "COMBINED HEREDITARY APC RESISTANCE AND ATIII TYPE-II DEFICIENCY ASSOCIATED WITH VENOUS THROMBOSIS", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CaZNVDsoPx4C", "citedby": "7"}, {"bib": {"title": "MODES OF ANTI-COAGULANT ACTION OF HUMAN PROTEIN-C, A VITAMIN-K-DEPENDENT SERINE PROTEASE", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wMgC3FpKEyYC", "citedby": "7"}, {"bib": {"title": "DUAL FUNCTION OF S-PROTEIN IN COMPLEMENT AND COAGULATION SYSTEMS OF HUMAN-PLASMA", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7wO8s98CvbsC", "citedby": "7"}, {"bib": {"title": "Multiple forms of active Hageman-factor (HF)(coagulation Factor-XII) produced during contact activation", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kw52XkFRtyQC", "citedby": "7"}, {"bib": {"title": "Inhibition of thrombin generation in human plasma by phospholipid transfer protein", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Kqc1aDSOPooC", "citedby": "6"}, {"bib": {"title": "Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:iKswqCX-FLkC", "citedby": "6"}, {"bib": {"title": "Muscarinic receptor antagonists", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1tZ8xJnm2c8C", "citedby": "6"}, {"bib": {"title": "Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XUvXOeBm_78C", "citedby": "6"}, {"bib": {"title": "Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5rMqqAh47xYC", "citedby": "6"}, {"bib": {"title": "Protective Effect of Activated Protein C in Murine Endotoxemia: Mechanism of Action.", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WHdLCjDvYFkC", "citedby": "6"}, {"bib": {"title": "Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:GJVTs2krol4C", "citedby": "6"}, {"bib": {"title": "Possible structural implications of 20 mutations in the protein C protease domain", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7H_MAutzIkAC", "citedby": "6"}, {"bib": {"title": "C-Terminal residues 621-635 of protein S are essential for binding to factor Va but not factor Xa", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g5Ck-dwhA_QC", "citedby": "6"}, {"bib": {"title": "High molecular weight kininogen receptor", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jgBuDB5drN8C", "citedby": "6"}, {"bib": {"title": "Immunological similarities between plasma and urinary protein C inhibitors (PCIs) and urinary urokinase inhibitor (UKI)", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CB2v5VPnA5kC", "citedby": "6"}, {"bib": {"title": "ROLE OF PROTEIN-C IN FIBRINOLYSIS", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PaBasH6fAo0C", "citedby": "6"}, {"bib": {"title": "HUMAN-PLATELET PROTEIN-S", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cK4Rrx0J3m0C", "citedby": "6"}, {"bib": {"title": "Activation of human Hageman factor by a leukocytic protease.", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4X0JR2_MtJMC", "citedby": "6"}, {"bib": {"title": "ROLE OF HUMAN PLATELETS IN CONTACT PHASE OF BLOOD-COAGULATION", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WC23djZS0W4C", "citedby": "6"}, {"bib": {"title": "The Hageman factor system: mechanism of contact activation", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MpfHP-DdYjUC", "citedby": "6"}, {"bib": {"title": "INVOLVEMENT OF HIGH MW KININOGEN (HK) IN SURFACE DEPENDENT REACTIONS OF HAGEMAN-FACTOR (HF)", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:48xauSegjOkC", "citedby": "6"}, {"bib": {"title": "Drug\u2013biomolecule interactions: Proton magnetic resonance studies of complex formation between bovine neurophysins and oxytocin at molecular level", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:U4n9YNQMCAIC", "citedby": "6"}, {"bib": {"title": "SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5LPo_wSKItgC", "citedby": "5"}, {"bib": {"title": "Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BW2nPTmhBn4C", "citedby": "5"}, {"bib": {"title": "Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of tPA and of tPA on the variant\u2019s anticoagulant activity", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:65Yg0jNCQDAC", "citedby": "5"}, {"bib": {"title": "Antibody SPC-54 provides acute in vivo blockage of the murine protein C system", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6bLC7aUMtPcC", "citedby": "5"}, {"bib": {"title": "Primary acute myeloid leukemia (AML) cells with the FLT3 internal tandem duplication (ITD) and absence of wild type (WT) FLT3 (FLT3 (ITD/-) genotype) are distinct from AML with \u2026", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j7_hQOaDUrUC", "citedby": "5"}, {"bib": {"title": "Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7BrZ7Jt4UNcC", "citedby": "5"}, {"bib": {"title": "Coagulation abnormalities in thrombosis. Hematology-1995.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:i91s68tWr-MC", "citedby": "5"}, {"bib": {"title": "METAL ION-DEPENDENT INHIBITION OF ACTIVATED PROTEIN-C (APC) BY ALPHA-2-MACROGLOBULIN (ALPHA-2M) AND ALPHA-2-ANTIPLASMIN (ALPHA-2AP) IN HUMAN BLOOD", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-95Q15plzcUC", "citedby": "5"}, {"bib": {"title": "ACTIVATED PROTEIN-C COMPLEXES WITH 2 PHYSIOLOGIC INHIBITORS-PROTEIN-C INHIBITOR AND ALPHA-1-ANTITRYPSIN", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KNjnJ3z-R6IC", "citedby": "5"}, {"bib": {"title": "Tryptase from human mast cells does not activate purified human Hageman factor", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LdasjJ6CEcoC", "citedby": "5"}, {"bib": {"title": "PROTEIN-S DEFICIENCY ASSOCIATED WITH THROMBOEMBOLIC DISEASE", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1taIhTC69MYC", "citedby": "5"}, {"bib": {"title": "Blood63, 486-489", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:I2jIoRS3jIgC", "citedby": "5"}, {"bib": {"title": "The possible role of platelets in bypassing the contact phase of blood coagulation.", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:v1_lew4L6wgC", "citedby": "5"}, {"bib": {"title": "The thrombin protecting function of a complement inhibitor in human plasma", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:w7CBUyPWg-0C", "citedby": "5"}, {"bib": {"title": "The Hageman factor system in inflammation", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:owLR8QvbtFgC", "citedby": "5"}, {"bib": {"title": "Cardiac and skeletal muscle myosin exert procoagulant effects", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YGhAHpnIhDoC", "citedby": "4"}, {"bib": {"title": "Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pUxgyZctzPYC", "citedby": "4"}, {"bib": {"title": "Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4QKQTXcH0q8C", "citedby": "4"}, {"bib": {"title": "Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:w0F2JDEymm0C", "citedby": "4"}, {"bib": {"title": "Estudio de las mesas de desarrollo rural en Uruguay como innovaci\u00f3n institucional para la participaci\u00f3n y la inclusi\u00f3n", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:I-2NeQpV75MC", "citedby": "4"}, {"bib": {"title": "Reversal of Novel Oral Anticoagulant (NOAC)-Induced Bleeding in Mice By Engineered superfactor Va", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oi2SiIJ9l4AC", "citedby": "4"}, {"bib": {"title": "Synergistic Effect in Bleed Reduction By superfva and Recombinant Human FVIIa in Vivo Suggests a Novel Bypassing Strategy for Hemophilia Patients with Inhibitors", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:O0nohqN1r9EC", "citedby": "4"}, {"bib": {"title": "Non-canonical cleavage of protease activated receptor 1 (PAR1) by activated protein C provides novel insights into the repertoire of cytoprotective and proinflammatory PAR1 \u2026", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QsaTk4IG4EwC", "citedby": "4"}, {"bib": {"title": "Enantiotracin", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vjZqxyZ7hS4C", "citedby": "4"}, {"bib": {"title": "Important of individual activated protein C (APC) cleavage sites in the heavy chain of factor V and Va (FV and FVa).", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wKETBy42zhYC", "citedby": "4"}, {"bib": {"title": "FUNCTIONAL-STUDIES OF FACTOR-VA (FVA) RESIDUES-493-506 RELATED TO ACTIVATED PROTEIN-C (APC) RESISTANCE", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:L1USKYWJimsC", "citedby": "4"}, {"bib": {"title": "127 Plasminogen activator inhibitor 3 (PAI-3, protein C inhibitor): Purification, characterization and specificity", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WC9gN4BGCRcC", "citedby": "4"}, {"bib": {"title": "PROTEIN-C IS ACTIVATED AND GIVES 110,000 MW COMPLEXES AND PROTEIN-S IS CLEAVED AND DECREASED INVIVO IN PATIENTS WITH INTRAVASCULAR COAGULATION (DIC)", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MhiOAD_qIWkC", "citedby": "4"}, {"bib": {"title": "STRUCTURAL-CHANGES OF HUMAN HIGH MW KININOGEN DURING CONTACT ACTIVATION OF PLASMA", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7Hz3ACDFbsoC", "citedby": "4"}, {"bib": {"title": "Molecular mechanisms of contact activation", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3NQIlFlcGxIC", "citedby": "4"}, {"bib": {"title": "PURIFICATION AND PROPERTIES OF HUMAN AND RABBIT HAGEMAN-FACTOR (HF)(COAGULATION FACTOR-XII)", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IaI1MmNe2tcC", "citedby": "4"}, {"bib": {"title": "Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cww_0JKUTDwC", "citedby": "3"}, {"bib": {"title": "Physiological cerebrovascular remodeling in response to chronic mild hypoxia: A role for activated protein C", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3vbIHxFL9FgC", "citedby": "3"}, {"bib": {"title": "Lyso-sulfatide binds factor Xa and inhibits thrombin generation by the prothrombinase complex", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:H7nrzBkawXsC", "citedby": "3"}, {"bib": {"title": "Novel antibacterial agents", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:B2rIPIGFPLEC", "citedby": "3"}, {"bib": {"title": "Cholesterol enhances phospholipid\u2010dependent activated protein C anticoagulant activity", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rHJHxKgnXwkC", "citedby": "3"}, {"bib": {"title": "Bicycle locking stand that prevents damage to urban trees", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pRWBApOjXDcC", "citedby": "3"}, {"bib": {"title": "Indolinone derivatives", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CCeGMaHljPEC", "citedby": "3"}, {"bib": {"title": "Protein kinase inhibitors", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MGPUR4WVBMEC", "citedby": "3"}, {"bib": {"title": "Monoclonal antibody S4 directed against the N-terminal region of protein S blocks protein S inhibition of prothrombinase in the absence of phospholipid", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1yWc8FF-_SYC", "citedby": "3"}, {"bib": {"title": "Activated protein C resistance", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SjuI4pbJlxcC", "citedby": "3"}, {"bib": {"title": "Inhibition of protein C activation by antiphospholipid antibodies in vitro is dependent on the composition of phospholipid (PL) of liposomes use as template.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1DsIQWDZLl8C", "citedby": "3"}, {"bib": {"title": "ANTITHROMBOTIC EFFECT OF COMBINING ACTIVATED PROTEIN-C WITH UROKINASE IN A PRIMATE MODEL OF ARTERIAL THROMBOSIS", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pAkWuXOU-OoC", "citedby": "3"}, {"bib": {"title": "ACTIVATED PROTEIN-C (APC) AND UROKINASE (UK) COMPETE FOR HEPARIN-DEPENDENT ASSOCIATION WITH PLASMA AND URINE COMPONENTS", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uVUOdF_882EC", "citedby": "3"}, {"bib": {"title": "QUANTITATIVE IMMUNOBLOTTING OF VITAMIN-K DEPENDENT COAGULATION-FACTORS IN PLASMA", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kzcSZmkxUKAC", "citedby": "3"}, {"bib": {"title": "Immunological Studies Of Human Factor XI", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-mN3Mh-tlDkC", "citedby": "3"}, {"bib": {"title": "DOES SOLUBLE ELLAGIC ACID ACTIVATE FACTOR-XII (HAGEMAN-FACTOR)", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ade32sEp0pkC", "citedby": "3"}, {"bib": {"title": "ANTI-THROMBIN III (ATIII) FUNCTIONS AS AN INHIBITOR OF MEMBRANE ATTACK COMPLEX (MAC) OF COMPLEMENT IN HUMAN-SERUM", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RoXSNcbkSzsC", "citedby": "3"}, {"bib": {"title": "CIRCULATING INHIBITORS OF BLOOD-COAGULATION DIRECTED AGAINST COMPONENTS OF CONTACT PHASE AND PROTHROMBIN ASSOCIATED WITH PROCAINAMIDE-INDUCED LUPUS-ERYTHEMATOSUS", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Br1UauaknNIC", "citedby": "3"}, {"bib": {"title": "Application of nuclear magnetic resonance spectroscopy to proteins", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hsZV8lGYWTMC", "citedby": "3"}, {"bib": {"title": "Vepoloxamer enhances fibrinolysis of tPA (tissue-type plasminogen activator) on acute ischemic stroke", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j7XjBeKFbTsC", "citedby": "2"}, {"bib": {"title": "Molecular interaction site on procoagulant myosin for factor Xa\u2013dependent prothrombin activation", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ynsZFq2pu0MC", "citedby": "2"}, {"bib": {"title": "Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cells", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cOfwuRB03ygC", "citedby": "2"}, {"bib": {"title": "Randomized, controlled, dose escalation trial of a protease-activated receptor-1 agonist in acute ischemic stroke: Final Results of the RHAPSODY trial.: A multi-center, Phase 2 \u2026", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:h1pkognVyKwC", "citedby": "2"}, {"bib": {"title": "SKELETAL MUSCLE MYOSIN HAS PRO-HEMOSTATIC ACTIVITY IN VIVO.", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_9Xh93LWpsYC", "citedby": "2"}, {"bib": {"title": "Regulation of immune cell signaling by activated protein C", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QKtdBID3u5MC", "citedby": "2"}, {"bib": {"title": "Control of Coagulation Reactions", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oYLFIHfuHKwC", "citedby": "2"}, {"bib": {"title": "R41Q-PAR1 Mutation Eliminates The Therapeutic Capacity Of Bone Marrow Derived Mesenchymal Stem Cells In Murine E Coli Pneumonia", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eH23hyXCXa4C", "citedby": "2"}, {"bib": {"title": "Gain in translation: heme oxygenase-1 induced by activated protein C promotes thrombus resolution", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qCpRzq7zkD8C", "citedby": "2"}, {"bib": {"title": "Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LXmCCkuhhTsC", "citedby": "2"}, {"bib": {"title": "Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-PI3K-Akt pathway through its SHBG-like region", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MNNNGtAgD4EC", "citedby": "2"}, {"bib": {"title": "Risk of Recurrent Venous Thromboembolism Reduced by High Density Lipoproteins.", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:An6A6Jpfc1oC", "citedby": "2"}, {"bib": {"title": "Calcium channel drugs and uses", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zdX0sdgBH_kC", "citedby": "2"}, {"bib": {"title": "Endothelial and Antithrombotic Actions of HDL", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:v_xunPV0uK0C", "citedby": "2"}, {"bib": {"title": "Method for diagnosis of thrombotic disorders", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1Ye0OR6EYb4C", "citedby": "2"}, {"bib": {"title": "Methods for diagnosing activated protein C resistance associated with a factor V genetic mutation and compositions thereof", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2v_ZtQDX9iAC", "citedby": "2"}, {"bib": {"title": "Molecular mechanism of mild/moderate hemophilia A: Substitution Ile2098Ser in the factor VIII (FVIII) C1 domain impairs FVIII binding to von Willebrand factor without altering \u2026", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jE2MZjpN3IcC", "citedby": "2"}, {"bib": {"title": "High density lipoprotein enhancement of the antithrombotic protein C pathway.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:q-HalDI95KYC", "citedby": "2"}, {"bib": {"title": "CARDIOLIPIN, A PROTEIN-C PATHWAY COFACTOR-IMPLICATIONS FOR ANTICARDIOLIPIN ANTIBODY SYNDROME", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mKu_rENv82IC", "citedby": "2"}, {"bib": {"title": "STUDIES OF SYNTHETIC PROTEIN-S EGF-1 DOMAIN, AN INHIBITOR OF THE ACTIVATED PROTEIN C-COFACTOR ACTIVITY OF PROTEIN-S", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:U_HPUtbDl20C", "citedby": "2"}, {"bib": {"title": "Venous thrombosis: how to make best use of the laboratory to guide therapy", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Dem6FJhTUoYC", "citedby": "2"}, {"bib": {"title": "LOW CIRCULATING ACTIVATED PROTEIN-C LEVELS IN ISCHEMIC STROKE", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-7ulzOJl1JYC", "citedby": "2"}, {"bib": {"title": "Identification of amino acids between residues 420 and 434 o protein S that are essential for binding to C4b binding protein using synthetic peptides and site directed mutagenesis", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sszUF3NjhM4C", "citedby": "2"}, {"bib": {"title": "IDENTIFICATION OF REGIONS OF PROTEIN-S ESSENTIAL FOR BINDING TO C4B-BINDING PROTEIN", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:xm0LlTxljI0C", "citedby": "2"}, {"bib": {"title": "Critical reevaluation of free protein S (PS) and C4b-binding protein (C4BP) levels and implications for thrombotic risk", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BrOSOlqYqPUC", "citedby": "2"}, {"bib": {"title": "RECOMBINANT ACTIVATED PROTEIN-C (R-APC) INHIBITION OF PLATELET-DEPENDENT THROMBOSIS", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-jrNzM816MMC", "citedby": "2"}, {"bib": {"title": "126 Complex formation between urokinase (uPA) and plasma protein C inhibitor (PCI) in vivo", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HGTzPopzzJcC", "citedby": "2"}, {"bib": {"title": "ACTIVATION AND COMPLEXATION OF PROTEIN-C AND CLEAVAGE OF PROTEIN-S IN PLASMA OF PATIENTS WITH INTRAVASCULAR COAGULATION (DIC)", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6_hjMsCP8ZoC", "citedby": "2"}, {"bib": {"title": "Mechanism of action of Protein C", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:w1MjKQ0l0TYC", "citedby": "2"}, {"bib": {"title": "IMMUNOLOGICAL STUDIES OF HUMAN HIGH MOLECULAR-WEIGHT KININOGEN (HMWK) USING MURINE MONOCLONAL-ANTIBODIES (MAB)", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MAUkC_7iAq8C", "citedby": "2"}, {"bib": {"title": "PROTEOLYSIS OF HUMAN FACTOR-VIII PROCOAGULANT PROTEIN WITH THROMBIN AND ACTIVATED PROTEIN-C", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Xl6nMSl579sC", "citedby": "2"}, {"bib": {"title": "Human Protein C, Its Inhibitor, And The Combined Deficiency Of Factors V And VIII", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3bvyWxjaHKcC", "citedby": "2"}, {"bib": {"title": "Mechanism of activation of human coagulation factor XI and plasma prekallikrein", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mWEH9CqjF64C", "citedby": "2"}, {"bib": {"title": "Structure-Function Relationships of Human High MW Kininogen (HMWK), A Cofactor in Contact Activation of Human Plasma", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WM2K3OHRCGMC", "citedby": "2"}, {"bib": {"title": "DEVELOPMENT OF A NEW ASSAY FOR THE ACTIVATION OF HUMAN COAGULATION FACTOR-X", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:v6i8RKmR8ToC", "citedby": "2"}, {"bib": {"title": "MECHANISM OF HAGEMAN-FACTOR ACTIVATION BY MONOSODIUM URATE CRYSTALS", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kWvqk_afx_IC", "citedby": "2"}, {"bib": {"title": "DFP STUDIES OF THE MECHANISM OF SURFACE-DEPENDENT REACTIONS OF HAGEMAN-FACTOR (HF, FACTOR-XII)", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AXkvAH5U_nMC", "citedby": "2"}, {"bib": {"title": "Blocking protein S improves hemostasis in hemophilia A and B", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NtGNdKbuCngC", "citedby": "1"}, {"bib": {"title": "Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:17ZO-CJnx_8C", "citedby": "1"}, {"bib": {"title": "Synergism of augmented FVa activity and recombinant human FVIIa represent a novel bypassing strategy in hemophilic patients with inhibitors", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cRMvf6lLvU8C", "citedby": "1"}, {"bib": {"title": "Removal of coagulation factors by the Gamunex\u00ae-C purification process", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:mel-f30kHHgC", "citedby": "1"}, {"bib": {"title": "Factor V inhibits PAR2-mediated lethal inflammation", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:k_7cPK9k7w8C", "citedby": "1"}, {"bib": {"title": "Activated protein C cellular pathways regulating thrombosis", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YlPif8NxrbYC", "citedby": "1"}, {"bib": {"title": "Stabilized proteins with engineered disulfide bonds", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kJDgFkosVoMC", "citedby": "1"}, {"bib": {"title": "Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WMtz-WDmgKQC", "citedby": "1"}, {"bib": {"title": "A disintegrin, rhodostomin, inhibits activities of LPS-treated monocytes via alphavbeta3 integrin: PP-MO-879", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WIXB4To3Tx4C", "citedby": "1"}, {"bib": {"title": "A disintegrin, rhodostomin, inhibits activities of LPS-treated monocytes via alphavbeta3 integrin: PP-MO-879", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8RAEygVn5_EC", "citedby": "1"}, {"bib": {"title": "Protein kinase inhibitors", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:prdVHNxh-e8C", "citedby": "1"}, {"bib": {"title": "Indolinone derivatives", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:htyGaKyDgHMC", "citedby": "1"}, {"bib": {"title": "Is adiponectin implicated in venous thromboembolism?", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:FiDNX6EVdGUC", "citedby": "1"}, {"bib": {"title": "Method for diagnosis of thrombotic disorders", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QVtou7C4vgoC", "citedby": "1"}, {"bib": {"title": "Up-regulated but insufficient generation of activated protein C is associated with development of multi-organ failure in severe acute pancreatitis", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TlpoogIpr_IC", "citedby": "1"}, {"bib": {"title": "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants.", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QUX0mv85b1cC", "citedby": "1"}, {"bib": {"title": "Activated protein C prevents N-methyl-D-aspartate induced apoptosis in mouse cortical neurons by blocking the expression of p53 through protease activated receptors 1 and 3", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Hck25ST_3aIC", "citedby": "1"}, {"bib": {"title": "Method for detecting the presence of protein C antibody in a fluid sample", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KaMxkj08jr0C", "citedby": "1"}, {"bib": {"title": "Conformational changes in activated protein C caused by binding of the EGF1 domain of protein S", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SGW5VrABaM0C", "citedby": "1"}, {"bib": {"title": "Extensive venous and arterial thrombosis in a patient with familial APC resistance without R506Q factor V mutation.", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PkcyUWeTMh0C", "citedby": "1"}, {"bib": {"title": "Brain-specific protein C activation during carotid artery occlusion in humans", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SIv7DqKytYAC", "citedby": "1"}, {"bib": {"title": "Impaired anticoagulant response to infusion of thrombin in monkeys with atherosclerosis and hyperhomocyst (e) inemia", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CYCckWUYoCcC", "citedby": "1"}, {"bib": {"title": "Arginine-306 is the most important activated protein C cleavage site for efficient inactivation of factor Va, but not of factor V", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:silx2ntsSuwC", "citedby": "1"}, {"bib": {"title": "Antithrombotic effects of selective activation of endogenous protein C", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zGdJYJv2LkUC", "citedby": "1"}, {"bib": {"title": "Binding sites for coagulation factor Xa and activated protein C involving residues 311-335 in factor Va", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jSAVyFp_754C", "citedby": "1"}, {"bib": {"title": "Anticoagulant protein C pathway upregulation by high density lipoprotein", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EPG8bYD4jVwC", "citedby": "1"}, {"bib": {"title": "A single genetic origin for the common Caucasian factor V mutation predisposing to thrombosis.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LGlY6t8CeOMC", "citedby": "1"}, {"bib": {"title": "Activated protein C resistance and central venous thrombosis after cardiac surgery in 2487 children.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uUvzmPk0f8oC", "citedby": "1"}, {"bib": {"title": "Prevalence of activated protein C resistance in children with thrombosis.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:UuEBAcK4md4C", "citedby": "1"}, {"bib": {"title": "Lack of correlation of inhibition of the protein C activation and prothrombinase reactions by antiphospholipid antibodies", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kF1pexMAQbMC", "citedby": "1"}, {"bib": {"title": "CHEMICAL SYNTHESIS OF THE THROMBIN-SENSITIVE REGION OF HUMAN PROTEIN-S AND CHARACTERIZATION OF ITS CLEAVAGE BY ALPHA-THROMBIN", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3lUAU8Oskd0C", "citedby": "1"}, {"bib": {"title": "THROMBOMODULIN INHIBITION OF THE PLASMIN SYSTEM", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8Xgff_V0N9gC", "citedby": "1"}, {"bib": {"title": "FACTOR-VA RESIDUES-491-525 RELATED TO APC RESISTANCE CONTRIBUTE TO MULTIPLE PROTEIN-BINDING SITES", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2l5NCbZemmgC", "citedby": "1"}, {"bib": {"title": "THE-1511 MUTATION IN THE PROTEIN-C GENE PROMOTER DISRUPTS THE BINDING-SITE FOR THE TRANSCRIPTIONAL ACTIVATOR, HEPATOCYTE NUCLEAR FACTOR-I (HNF-1)", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:F2UWTTQJPOcC", "citedby": "1"}, {"bib": {"title": "Anticoagulant response to activated protein C: method validation and assay comparison", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:L24QuVWYgZ0C", "citedby": "1"}, {"bib": {"title": "RECOMBINANT ACTIVE-SITE MUTANT S360A-PROTEIN-C WITH NONENZYMATIC ANTICOAGULANT ACTIVITY", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DkZNVXde3BIC", "citedby": "1"}, {"bib": {"title": "PROTEIN-S-A NATURAL SUBSTRATE OF THE KIDNEY AND BRAIN GAMMA-CARBOXYLASES", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:27LrP4qxOz0C", "citedby": "1"}, {"bib": {"title": "3-DIMENSIONAL ANALYSIS OF PROTEASE DOMAIN AMINO-ACID MUTATIONS IN INHERITED PROTEIN-C DEFICIENCY", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:raTqNPD5sRQC", "citedby": "1"}, {"bib": {"title": "Heparin stimulates thrombin inhibition but not APC inhibition by recombinant PAI-1 and strained loop PAI-1 mutants", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IsPWOBWtZBwC", "citedby": "1"}, {"bib": {"title": "ELISA ASSAYS FOR PROTEIN-C INHIBITOR (PCI, PAI-3)-HEPARIN-INDUCED DECREASE IN CIRCULATING PROTEIN-C INHIBITOR", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9NZAP19TdFAC", "citedby": "1"}, {"bib": {"title": "APROTININ (TRASYLOL) IS A COMPETITIVE INHIBITOR OF ACTIVATED PROTEIN-C", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DrR-2ekChdkC", "citedby": "1"}, {"bib": {"title": "Familial protein S deficiency with a variant protein S molecule in plasma and platelets", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YsrPvlHIBpEC", "citedby": "1"}, {"bib": {"title": "Functional characterization of protein C inhibitors (PCI) from plasma and urine", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PyEswDtIyv0C", "citedby": "1"}, {"bib": {"title": "Protein C and Protein S Defects in Thromboembolic Disease", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qwy9JoKyICEC", "citedby": "1"}, {"bib": {"title": "MONOCLONAL-ANTIBODY IMMUNOBLOTTING STUDIES OF PROTEIN-C (PC) AND COMPLEXES OF ACTIVATED PROTEIN-C (APC) IN PLASMA", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-nhnvRiOwuoC", "citedby": "1"}, {"bib": {"title": "RFA Zwaal and HC Hemker (Eds.), Blood Coagulation\u00a9 1986 Elsevier Science Publishers BV (Biomedical Division)", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yeL6HyUMUGUC", "citedby": "1"}, {"bib": {"title": "The function of the heavy and light chain of human plasma kallikrein in the activation of factor XII.", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hGdtkIFZdKAC", "citedby": "1"}, {"bib": {"title": "Protein S und ven\u00f6se Thrombophilie", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u0Mu_IsstPMC", "citedby": "1"}, {"bib": {"title": "ZINC-DEPENDENT RECEPTORS FOR CONTACT ACTIVATION FACTORS ON HUMAN-PLATELETS", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7H_jS4BsgvYC", "citedby": "1"}, {"bib": {"title": "Studies of protein C in thromboembolic disease", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:5bg8sr1QxYwC", "citedby": "1"}, {"bib": {"title": "A COUMARIN-RESPONSIVE PURPURA FULMINANS SYNDROME IN A NEONATE WITH INHERITED PROTEIN-C DEFICIENCY", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JTqpx9DYBaYC", "citedby": "1"}, {"bib": {"title": "SULFATIDE-DEPENDENT AUTOACTIVATION OF HUMAN-BLOOD COAGULATION FACTOR-XII", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HJSXoJQnj-YC", "citedby": "1"}, {"bib": {"title": "Activation of the intrinsic fibrinolytic system via the factor XII dependent pathway", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yxmsSjX2EkcC", "citedby": "1"}, {"bib": {"title": "PLATELETS POTENTIATE COAGULANT ACTIVITY OF CONTACT FACTORS", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pS0ncopqnHgC", "citedby": "1"}, {"bib": {"title": "Platelet-Dependent proteolytic activation of factor XI", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IvSMUa3B7yYC", "citedby": "1"}, {"bib": {"title": "Inhibition of the Activities of \u03b12-Plasmin Inhibitor (PI) and C\u012a Inhibitor (C\u012a-Inh by the Synthetic Fibrinolytic Agent, 3-Hydroxypropyl Flufenamide (Flu-HPA)", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RJNGbXJAtMsC", "citedby": "1"}, {"bib": {"title": "Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jlhcAiayVhoC", "citedby": "1"}, {"bib": {"title": "IMMUNOLOGICAL STUDIES OF HUMAN HIGH AND LOW MW KININOGENS", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:69ZgNCALVd0C", "citedby": "1"}, {"bib": {"title": "HUMAN FACTOR-VII ACTIVATION-ROLE OF HUMAN FACTOR XII-ALPHA KALLIKREIN AND FACTOR IX-ALPHA", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rbm3iO8VlycC", "citedby": "1"}, {"bib": {"title": "Mechanism of Activation of Human Factor IX by Activated Human Factor XI", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:X9ykpCP0fEIC", "citedby": "1"}, {"bib": {"title": "ACTIVITIES OF MULTIPLE FORMS OF HAGEMAN-FACTOR PRODUCED DURING CONTACT ACTIVATION OF PLASMA", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qe6vwMD2xtsC", "citedby": "1"}, {"bib": {"title": "ACTIVATION OF HUMAN COAGULATION FACTOR-IX BY HUMAN ACTIVATED FACTOR-XI", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ziOE8S1-AIUC", "citedby": "1"}, {"bib": {"title": "FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IExZWSxeYXUC", "citedby": "0"}, {"bib": {"title": "C\u2010terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:FQ36aI_S1AEC", "citedby": "0"}, {"bib": {"title": "Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nroGzMJTTpEC", "citedby": "0"}, {"bib": {"title": "Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jRIwE-1ttnoC", "citedby": "0"}, {"bib": {"title": "Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3x-KLxxGyuUC", "citedby": "0"}, {"bib": {"title": "Novel exomic rare variants associated with venous thrombosis", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Oj-SLI0tZTcC", "citedby": "0"}, {"bib": {"title": "Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9tXw7Op4-u0C", "citedby": "0"}, {"bib": {"title": "Materials and methods for treating or preventing graft-versus-host-disease", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DUFsPKDdMi0C", "citedby": "0"}, {"bib": {"title": "Abstract TMP27: Par1 Mediates Protective Effect of 3K3K-APC After White Matter Stroke in Mice", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jq04SsiGh3QC", "citedby": "0"}, {"bib": {"title": "Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients", "year": "2020"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:37Fl7vPTsUIC", "citedby": "0"}, {"bib": {"title": "Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:o-PowTg_VKEC", "citedby": "0"}, {"bib": {"title": "Molecular Interaction Site on Procoagulant Skeletal Muscle Myosin for Factor Xa-Dependent Prothrombin Activation", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BFa5h04uPMwC", "citedby": "0"}, {"bib": {"title": "Factor VIIa Induces Biased Cytoprotective Signaling through the Cleavage of Protease Activated Receptor 1 at Canonical Arg41 Site", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:U3qCfcK-7lkC", "citedby": "0"}, {"bib": {"title": "Cardiac Myosin Acts Is a Potent Procoagulant in Vitro and In Vivo", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hB2aVRuWZNwC", "citedby": "0"}, {"bib": {"title": "Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AFXcoJnoRH0C", "citedby": "0"}, {"bib": {"title": "Neuroprotection and vasculoprotection using genetically targeted protease-ligands", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IyxfXMz2bNAC", "citedby": "0"}, {"bib": {"title": "MRI Evaluation and Functional Assessment of Brain Injury Improvement After 3K3A-Activated Protein C Treatment for Murine White Matter Stroke", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9VeumLvkZSQC", "citedby": "0"}, {"bib": {"title": "Abstract WP139: MRI Evaluation and Functional Assessment of Brain Injury Improvement After 3K3A-Activated Protein C Treatment for Murine White Matter Stroke", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u_mOZUIutIEC", "citedby": "0"}, {"bib": {"title": "Randomized, controlled, dose escalation trial of a protease-activated receptor-1 agonist in acute ischemic stroke: Final Results of the RHAPSODY trial.: A multi-center, Phase 2 \u2026", "year": "2019"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3_f9JqYsqVQC", "citedby": "0"}, {"bib": {"title": "CHARACTERIZATION OF AN EXOSITE IN C-TERMINUS OF THE ACTIVATED PROTEIN C LIGHT CHAIN FOR ANTICOAGULANT AND CYTOPROTECTIVE ACTIVITIES", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4oJvMfeQlr8C", "citedby": "0"}, {"bib": {"title": "Protein S released from platelets limits thrombus growth", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nU66GSXDKhoC", "citedby": "0"}, {"bib": {"title": "Cardiac Myosin Promotes Thrombin Generation and Attenuates Tissue Plasminogen Activator-induced Plasma Clot Lysis", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vofGIMt6cyEC", "citedby": "0"}, {"bib": {"title": "Skeletal Muscle Myosin Supports the Anticoagulant Functions of Activated Protein C and Protein S but not Protein C Activation by Thrombin: Thrombomodulin", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NnTm98qLMbgC", "citedby": "0"}, {"bib": {"title": "Design of a programmable and tunable semi-synthetic clot buster", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:It0W0vAlS5QC", "citedby": "0"}, {"bib": {"title": "Abstract WP90: Activate Protein C Analog Protects Ischemic Injury of Subcortical White Matter in Mice", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cB__R-XWw9UC", "citedby": "0"}, {"bib": {"title": "Scientific Category: Thrombosis and Hemostasis", "year": "2018"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KsTgnNRry18C", "citedby": "0"}, {"bib": {"title": "Activated Protein C Light Chain Provides an Extended Binding Surface for Anticoagulant Cofactor Protein S", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NU-BerS4NX4C", "citedby": "0"}, {"bib": {"title": "Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods", "year": "2017"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Azgs6IHzeyYC", "citedby": "0"}, {"bib": {"title": "Activated Protein C (APC) Therapy Ameliorates Chronic Graft Versus Host Disease By Cell Signaling Mechanisms That Require Cleavage at Arg46 in PAR1 on T Cells", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M0j1y4EgrScC", "citedby": "0"}, {"bib": {"title": "Novel R41Q- and R46Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for In Vivo Protective Mechanisms of Action for Activated Protein C (APC) in Sepsis \u2026", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:K4-iKlO5MD4C", "citedby": "0"}, {"bib": {"title": "Thrombotic Stroke: Neuroprotective Therapy by Recombinant Activated Protein C", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ShjGdcaqzI0C", "citedby": "0"}, {"bib": {"title": "Activated protein C (APC) down regulates neutrophil extracellular traps (NETs): potential contributing mechanism for anti-inflammatory and antithrombotic effects Of APC", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Gpwnp1kGG20C", "citedby": "0"}, {"bib": {"title": "Blood First Edition Paper, prepublished online July 15, 2016; DOI 10.1182/blood-2016-03-707679", "year": "2016"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oldoQiaHq2UC", "citedby": "0"}, {"bib": {"title": "Methods for treating and preventing radiation injury using activated protein c polypeptides", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AYInfyleIOsC", "citedby": "0"}, {"bib": {"title": "Role of Protein S and Gas6 in the Development of Purpura Fulminans", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rFyVMFCKTwsC", "citedby": "0"}, {"bib": {"title": "Coagulation Factor V Mediates Inhibition of Tissue Factor Signaling By Activated Protein C", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Oo1CbQkBAzEC", "citedby": "0"}, {"bib": {"title": "Exome Genotyping Links Venous Thrombosis Risk with the Skeletal Muscle Myosin Gene Cluster and Leads to Discovery of New Family of Procoagulant Factors", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:d4tt_xEv1X8C", "citedby": "0"}, {"bib": {"title": "Plasma Constitutive Serum Amyloid A4 Is Procoagulant and Is Elevated in Venous Thrombosis Patients", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:natZJ_-F0IUC", "citedby": "0"}, {"bib": {"title": "Modification of a thrombin generation test to identify new cofactors of the protein C pathway in plasma: PO093-MON", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:X4-KO54GjGYC", "citedby": "0"}, {"bib": {"title": "Elevated Plasma CETP Activity and Hyper-procoagulant R451Q-CETP Mutation Linked to Venous Thrombosis Risk", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:z8nqeaKD1nsC", "citedby": "0"}, {"bib": {"title": "Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VjBpw8Hezy4C", "citedby": "0"}, {"bib": {"title": "D102 ADVANCES IN LUNG IMMUNOLOGY AND SARCOIDOSIS: R41q-Par1 Mutation Eliminates The Therapeutic Capacity Of Bone Marrow Derived Mesenchymal Stem Cells In Murine E Coli Pneumonia", "year": "2015"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Gb6Hms-Uo9kC", "citedby": "0"}, {"bib": {"title": "Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RtRctb2lSbAC", "citedby": "0"}, {"bib": {"title": "Novel R41Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for in Vivo Mechanisms of Action for Thrombin (IIa) and Activated Protein C (APC)", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:L_l9e5I586QC", "citedby": "0"}, {"bib": {"title": "RECENT STUDIES OF HUMAN HIGH MOLECULAR WEIGHT KININOGEN", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3_LpOwP6eMYC", "citedby": "0"}, {"bib": {"title": "C0136: A Modification of Calibrated Automated Thrombin Generation Assay to Explore New Cofactors of Activated Protein C in Plasma", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zwpXiJ37cpgC", "citedby": "0"}, {"bib": {"title": "C0047: Cytoprotective Selective Human 3K3A-Activated Protein C Variant Detoxifies Histone H1 and Stabilizes Endothelium from Pro-Inflammatory Cytokines", "year": "2014"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:c1e4I3QdEKYC", "citedby": "0"}, {"bib": {"title": "An activated protein C analog protects from ischemic stroke and extends the therapeutic window of tPA in aged female mice and hypertensive rats", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PlWzFYVEG4EC", "citedby": "0"}, {"bib": {"title": "Activation-Resistant Homozygous Protein C R229W Mutation Causing Familial Perinatal Intracranial Hemorrhage", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:inmFHauC9wsC", "citedby": "0"}, {"bib": {"title": "Reduction Of Histone H1 Cytotoxicity By Activated Protein C and Its Exosite Variants", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sfnaS5RM6jYC", "citedby": "0"}, {"bib": {"title": "An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EsEWqaRxkBgC", "citedby": "0"}, {"bib": {"title": "Influence of the 3K3A-activated protein C variant on thein vitrofibrinolytic activity of tPA: PB 2.56\u20132", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hefNtdE4IMkC", "citedby": "0"}, {"bib": {"title": "Investigation on the role of protein S in platelets: AS 03.1", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CMvovTBb2okC", "citedby": "0"}, {"bib": {"title": "Autodegradation of murine activated protein C due to cleavage at Lys43: PA 1.15\u20134", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PVqtIyvKoSUC", "citedby": "0"}, {"bib": {"title": "Cardioprotective effects of EWE thrombin, a selective protein C activator, in a mouse model of acute focal myocardial ischemia and reperfusion: AS 07.3", "year": "2013"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:t-hv7AR41mYC", "citedby": "0"}, {"bib": {"title": "This presentation concerns a description of the functions of protein C and", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:s85pQhAUCrAC", "citedby": "0"}, {"bib": {"title": "In Vitro and in Vivo Neutralization of Murine Activated Protein C", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:u3T1itk59dMC", "citedby": "0"}, {"bib": {"title": "Protection Against Vascular Leakage in Vivo by a Peptide Mimetic of the Novel Tethered Ligand Generated by Non-Canonical Cleavage of Protease Activated Receptor 1 by Activated \u2026", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cNe27ouKFcQC", "citedby": "0"}, {"bib": {"title": "Superior in Vivo Hemostatic Properties of an Engineered Factor Va Variant for Hemophilia Mice", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RMgMIBzvq-4C", "citedby": "0"}, {"bib": {"title": "Activated Protein C, Sepsis, and the Innate Immune Response to Infection", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:c59VksA5Vz4C", "citedby": "0"}, {"bib": {"title": "Activated Protein C Cytoprotective Signaling in Endothelial Cells Involves apoER2 and Disabled-1", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hQUaER0FWQ4C", "citedby": "0"}, {"bib": {"title": "An engineered\" super\" factor Va mutant as a potential bypassing agent in hemophilia: FP-TU-01.1-1", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oursBaop5wYC", "citedby": "0"}, {"bib": {"title": "Antibacterial fluoroquinolone analogs", "year": "2012"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rLGzs9wiiwIC", "citedby": "0"}, {"bib": {"title": "Warfarin Untargeted Metabolomics Study Identifies Novel Procoagulant Ethanolamide Lipids", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tBlTYpvFGQIC", "citedby": "0"}, {"bib": {"title": "Plasma High Density Lipoprotein and Anticoagulant Response to Activated Protein C (APC) and Protein S", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ej9njvOgR2oC", "citedby": "0"}, {"bib": {"title": "Insight in Protein S Deficiency From Mouse Models", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Vr2j17o0sqMC", "citedby": "0"}, {"bib": {"title": "A paired LC-MS/MS untargeted metabolomics investigation of plasma from patients on warfarin identifies novel procoagulant plasma lipids: P-TH-130", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Vztgr1qGG8IC", "citedby": "0"}, {"bib": {"title": "Elevated serum amyloid a is associated with blood coagulability and with venous thromboembolism: P-WE-143", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RfUwGJFMQ-0C", "citedby": "0"}, {"bib": {"title": "HDL freshly isolated by ultracentrifugation from plasma is a cofactor for activated protein C (APC)/protein s anticoagulant activity: controversy and reevaluation: O-MO-013", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RXiHnyRawswC", "citedby": "0"}, {"bib": {"title": "Lyso-sulfatide binds factor Xa outside of the Gla domain and potently inhibits thrombin generation: P-WE-117", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:orDZ08hpP44C", "citedby": "0"}, {"bib": {"title": "Therapeutic efficacy of activated protein C in murine endotoxemia: SY-TH-021", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nPT8s1NX_-sC", "citedby": "0"}, {"bib": {"title": "Protein S protects the nervous system from injury", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:X0DADzN9RKwC", "citedby": "0"}, {"bib": {"title": "In vivo and in vitro complexes of activated protein C with two", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:xyvS_IvSCKsC", "citedby": "0"}, {"bib": {"title": "Reevaluation of total, free, and bound protein S and C4b-binding", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lbI08cpqPnQC", "citedby": "0"}, {"bib": {"title": "Venous thromboembolism associated with double heterozygosity for", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Og1tA8FjbJAC", "citedby": "0"}, {"bib": {"title": "Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dAp6zn-oMfAC", "citedby": "0"}, {"bib": {"title": "Low total protein S antigen but high protein S activity due to decreased", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:unp9ATQDT5gC", "citedby": "0"}, {"bib": {"title": "Comparison of anticoagulant and procoagulant activities of stimulated", "year": "2011"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SAZ1SQo2q1kC", "citedby": "0"}, {"bib": {"title": "Novel Infrared Fluorescence Methodology Defines An Essential Role for Endothelial Protein C Receptor (EPCR) for Protection Against Vascular Leakage In Inflammation", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yIeBiWEAh44C", "citedby": "0"}, {"bib": {"title": "Lyso-Sulfatide Binds Factor Xa and Potently Inhibits Thrombin Generation.", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yTLRzDEmwhEC", "citedby": "0"}, {"bib": {"title": "Plasma Serum Amyloid A Levels Are Increased In Venous Thrombosis Patients and Are Correlated with Blood Coagulability", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wE-fMHVdjMkC", "citedby": "0"}, {"bib": {"title": "Dosing regimen of activated protein c and variants having reduced anticoagulant activity", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4e5Qn2KL_jwC", "citedby": "0"}, {"bib": {"title": "Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:HqhvjgTjE9cC", "citedby": "0"}, {"bib": {"title": "Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity", "year": "2010"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KWzIFqRkAKkC", "citedby": "0"}, {"bib": {"title": "Muscarinic receptor antagonists", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ujxm2eEBZHIC", "citedby": "0"}, {"bib": {"title": "Drug engineering of dual-acting HMG-CoA reductase+ p38 alpha MAP kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IT1MJ6E3JesC", "citedby": "0"}, {"bib": {"title": "Efficacy of activated protein C variants in murine sepsis models: PP-MO-881", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KIRwYnRZzWQC", "citedby": "0"}, {"bib": {"title": "Control of innate immunity by activated protein C: PP-MO-880", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1wZ_wKGpLuwC", "citedby": "0"}, {"bib": {"title": "Vascular and innate immune cell signaling contribute to lethality protection by activated protein C in murine sepsis models: AS-TU-043", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wBLCggQE-ToC", "citedby": "0"}, {"bib": {"title": "RETRACTION: Niessen F, Furlan-Freguia C, Fern\u00e1ndez JA, Mosnier LO", "year": "2009"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:S2WlVNSe3u4C", "citedby": "0"}, {"bib": {"title": "Activation of the PI3K-Akt Pathway by Activated Protein C Occurs Via a Novel Receptor, Apolipoprotein E Receptor 2 (ApoER2)", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Nw_I7GeUguwC", "citedby": "0"}, {"bib": {"title": "Factor V as Anticoagulant Cofactor for Activated Protein C in Factor Va Inactivation", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eAlLMO4JVmQC", "citedby": "0"}, {"bib": {"title": "Dyslipoproteinemia Associated with Venous Thrombosis", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:X5YyAB84Iw4C", "citedby": "0"}, {"bib": {"title": "Role of factor V Leiden in bacterial infection: Implications for sepsis therapy with activated protein C", "year": "2008"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XDrR66g3YHsC", "citedby": "0"}, {"bib": {"title": "In Vivo Anti-Thrombotic Potency of Engineered Activated Protein C Variants.", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Tfl4UtY-dJUC", "citedby": "0"}, {"bib": {"title": "Preservation of Beneficial TAFI Functions by an Activated Protein C Variant with Normal Cytoprotective Functions but Minimal Anticoagulant Activity.", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:U0iAMwwPxtsC", "citedby": "0"}, {"bib": {"title": "Preservation of beneficial TAFI functions by an activated protein C variant with normal cytoprotective functions but minimal anticoagulant activity", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:D_tqNUsBuKoC", "citedby": "0"}, {"bib": {"title": "Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ybfzIt2tCtgC", "citedby": "0"}, {"bib": {"title": "Indolinone derivatives", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Xz60mAmATU4C", "citedby": "0"}, {"bib": {"title": "PMCID: PMC1828610.", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g30IDTdgJMgC", "citedby": "0"}, {"bib": {"title": "Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MDX3w3dAD3YC", "citedby": "0"}, {"bib": {"title": "Activated protein C inhibits prohemorrhagic tPA-MMP-9 pathway in ischemic brain endothelium via protease activated receptor 1 (PAR-1)", "year": "2007"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:naSTrk-c4S8C", "citedby": "0"}, {"bib": {"title": "Dyslipoproteinemia associated with venous thrombosis", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:OzeSX8-yOCQC", "citedby": "0"}, {"bib": {"title": "Platelet Factor 4 (PF4) Modulation of Endothelial Protein C Receptor and Thrombomodulin Enhancements of Protein C Activation and TAFI Activation by Thrombin.", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:e84hm74t-eoC", "citedby": "0"}, {"bib": {"title": "Anti-Inflammatory and Anti-Apoptotic Activities of Activated Protein C Are Independent of Anticoagulant Activity.", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:m92CDrhVnKEC", "citedby": "0"}, {"bib": {"title": "A Novel ELISA for Mouse Activated Protein C in Plasma Based on Interspecies Inhibition by Human Protein C Inhibitor: ID: 068", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yY3RG6sOEgwC", "citedby": "0"}, {"bib": {"title": "Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wuD5JclIwkYC", "citedby": "0"}, {"bib": {"title": "Antibacterial agents", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:A8cqit5AE6sC", "citedby": "0"}, {"bib": {"title": "Protein kinase inhibitors", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:I9gX6wnfuA8C", "citedby": "0"}, {"bib": {"title": "High Density Lipoprotein (HDL) Protects against Venous Thrombosis: P279", "year": "2006"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nPTYJWkExTIC", "citedby": "0"}, {"bib": {"title": "Efficient Barrier Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells.", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DQNrXyjhriIC", "citedby": "0"}, {"bib": {"title": "Activated Protein C Light Chain Mutations Distinguish Exosite Residue Requirements for Anticoagulant Versus Cytoprotective Activities.", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KI9T_ytC6pkC", "citedby": "0"}, {"bib": {"title": "INTRAHEPATIC PROTEIN C ACTIVATION REDUCES PHAGOCYTE ACTIVATION DURING REPERFUSION IN HUMAN LIVER TRANSPLANTATION: PO-893", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DIubQTN3OvUC", "citedby": "0"}, {"bib": {"title": "Novel antibacterial agents", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:kvJssbFybhEC", "citedby": "0"}, {"bib": {"title": "Sex, statins, and stroke outcomes in patients with vascular disease", "year": "2005"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eAUscmXIlQ8C", "citedby": "0"}, {"bib": {"title": "Targeted Replacement of the Murine Thrombomodulin Gene with Human Thrombomodulin Coding Sequence Results in Decreased Protein C Activation and Enhanced Thrombotic Response to \u2026", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8uzoZH4hB9AC", "citedby": "0"}, {"bib": {"title": "Sustained Pharmacological Activation of Protein C (PC) in Baboons.", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4aZ_i-5WJEQC", "citedby": "0"}, {"bib": {"title": "Factor Xa Binding Sites on Factor Va in the Prothrombinase Complex.", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:CNPyR2KL9-0C", "citedby": "0"}, {"bib": {"title": "INTRAHEPATIC PROTEIN C ACTIVATION DURING REPERFUSION IN HUMAN LIVER TRANSPLANTATION REDUCES PHAGOCYTE ACTIVATION", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:T_ojBgVMvoEC", "citedby": "0"}, {"bib": {"title": "Protein C activation may down-regulate phagocyte activation during reperfusion in liver transplantation", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:KTwcwpFFj4wC", "citedby": "0"}, {"bib": {"title": "Predictors of gastrointestinal bleeding in patients receiving thrombolytic therapies for acute ST-elevation myocardial infarction", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oAywNP-vUhwC", "citedby": "0"}, {"bib": {"title": "Clinical Investigation and Reports-Differential Treatment Benefit of Platelet Glycoprotein IIb/IIIa Inhibition With Percutaneous Coronary Intervention Versus Medical Therapy \u2026", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vD2iS2Kej30C", "citedby": "0"}, {"bib": {"title": "Ly315920na/s-5920, a selective inhibitor of group IIa secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:IHkkN1K1AlAC", "citedby": "0"}, {"bib": {"title": "Prothrombin Residues 473 to 487 Contribute To Factor Va Binding in the Prothrombinase Complex.(Poster# 874-I)", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j8pvxH-kN2QC", "citedby": "0"}, {"bib": {"title": "Cardiac Tamponade in the Fibrinolytic Area: Analysis of over 100.000 ST-Segment Myocardial Infraction Patients", "year": "2004"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sJPMR1oEGYQC", "citedby": "0"}, {"bib": {"title": "Functional characterization and proteolytic inactivation of novel engineered disulfide-bond-stabilized human factor VIIIa variants.", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rqnDXT1GswoC", "citedby": "0"}, {"bib": {"title": "Activated protein C (APC) in vivo neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eI34FqJmdUoC", "citedby": "0"}, {"bib": {"title": "Anticoagulant activated protein C directly inhibits staurosporin-induced apoptosis via protease activated receptor-1", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nqdriD65xNoC", "citedby": "0"}, {"bib": {"title": "Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium through endothelial protein C receptor and protease-activated receptor", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zdjWy_NXXwUC", "citedby": "0"}, {"bib": {"title": "HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY-Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and \u2026", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NtCmTCuxid4C", "citedby": "0"}, {"bib": {"title": "Activated protein C prevents p53-mediated apoptosis in hypoxic human brain endothelium by activating protease activated receptor-1", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rOcdG6UcVlcC", "citedby": "0"}, {"bib": {"title": "Activated protein C acts directly on human brain endothelial cells and is a potent mitogen on human brain vascular smooth cells", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bVQMTfhMCi4C", "citedby": "0"}, {"bib": {"title": "ENZYME CATALYSIS AND REGULATION-Identification of Distinct Sequences in Human Blood Coagulation Factor Xa and Prothrombin Essential for Substrate and Cofactor Recognition in \u2026", "year": "2003"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:x21FZCSn4ZoC", "citedby": "0"}, {"bib": {"title": "Venous thrombosis and plasma glucosylceramide deficiency, LDL, and HDL", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:In6cVmBjs0IC", "citedby": "0"}, {"bib": {"title": "ENZYME CATALYSIS AND REGULATION-Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.", "year": "2002"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:dFKc6_kCK1wC", "citedby": "0"}, {"bib": {"title": "Effect of hyperhomocysteinemia on protein C activation and activity in vivo.", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oqD4_j7ulsYC", "citedby": "0"}, {"bib": {"title": "Impaired anticoagulant response to thrombin improves after regression of atherosclerosis in monkeys.", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:aEW5N-EHWIMC", "citedby": "0"}, {"bib": {"title": "Mechanism of glucosylceramide anticoagulant cofactor activity for the protein C pathway leading to antithrombotic microdomain hypothesis.", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TaaCk18tZOkC", "citedby": "0"}, {"bib": {"title": "Platlet factor 4 enhances generation of activated protein C in vitro and in vivo.", "year": "2001"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ZqE1mSdD_DYC", "citedby": "0"}, {"bib": {"title": "Hemostatic system in early respiratory distress syndrome: Reduced fibrinolytic state.", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-38epGy1wY0C", "citedby": "0"}, {"bib": {"title": "ENZYME CATALYSIS AND REGULATION-Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than \u2026", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lYAcb2jw7qUC", "citedby": "0"}, {"bib": {"title": "HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY-The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites", "year": "2000"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hvmnpdAuIbkC", "citedby": "0"}, {"bib": {"title": "Inactivation of activated TAFI takes place by a process that involves conformational instability and not proteolytic cleavage.", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BmWJbWwHJAwC", "citedby": "0"}, {"bib": {"title": "Factor XI dependent and independent activation of TAFI in plasma during clot formation", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:w2UhwfzvF0QC", "citedby": "0"}, {"bib": {"title": "Three-dimensional homology model of the complete coagulation factor Va molecule in complex with activated protein C", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:3A3nxV7CjKIC", "citedby": "0"}, {"bib": {"title": "Phospholipid-dependent protein S interaction with factor Xa mediated through the thrombin-sensitive region of protein S", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Y9VhQm-5nPIC", "citedby": "0"}, {"bib": {"title": "Structural basis for hemophilia A caused by mutations in the C2 domain of factor VIII", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:VRfTbSk87rEC", "citedby": "0"}, {"bib": {"title": "Identification of the cleavage sites in thrombin-activatable fibrinolysis inhibitor upon activation by thromblin/thrombomodulin using matrix-assisted laser desorption \u2026", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ifOnle78iJkC", "citedby": "0"}, {"bib": {"title": "Cardiolipin is a normal component", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oTdOBqtIf_kC", "citedby": "0"}, {"bib": {"title": "Inhibition of prothrombinase by group II secretory phospholipase A (2), involves binding to factor Xa", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:DXE8ND7PrJAC", "citedby": "0"}, {"bib": {"title": "Activated protein C (APC) resistance assay sensitive to HDL anticoagulant activity", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jmjb1lOE9QIC", "citedby": "0"}, {"bib": {"title": "Sterol biosynthesis inhibitors with potent activity against Trypanosoma cruzi and Leishmania mexicana", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tHtfpZlB6tUC", "citedby": "0"}, {"bib": {"title": "Molecular mechanis of mild/moderate hemophilia A: substitution ILE2098SER in the Factor FVIII (FVIII) C1 domain impairs FVIII binding to von Willebrand factor without altering \u2026", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:tz746QTLzJkC", "citedby": "0"}, {"bib": {"title": "CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein", "year": "1999"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:W2uZP3ddy8sC", "citedby": "0"}, {"bib": {"title": "Extensive venous and arterial thrombosis induced by acquired specific antibodies to activated protein.", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:z6xuaG2dYH0C", "citedby": "0"}, {"bib": {"title": "Recombinant human soluble thrombomodulin inhibition of thrombus formation in non-human primates", "year": "1998"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:N4u4nq0IxgcC", "citedby": "0"}, {"bib": {"title": "Activated protein C resistance in patients with venous thromboembolism following total joint replacement.", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_tF6a-HnqWAC", "citedby": "0"}, {"bib": {"title": "Impaired protein C activation in monkeys with atherosclerosis and hyperhomocyst (e) inemia", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wLxue7F8ec0C", "citedby": "0"}, {"bib": {"title": "Fully active synthetic human secretory phospholipase A (2) inhibits prothrombinase complex activity", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:v_tt_AnqfNMC", "citedby": "0"}, {"bib": {"title": "Anticoagulant synergism of heparins and other glycosaminoglycans with activated protein C", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:M0leSnx2MbUC", "citedby": "0"}, {"bib": {"title": "The anticoagulant action of human secretory phospholipase A (2) is due to the inhibition of factor Xa", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:R-LXmdHK_14C", "citedby": "0"}, {"bib": {"title": "Factor V residues 493-506 bind factor Xa", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:__bU50VfleQC", "citedby": "0"}, {"bib": {"title": "HDL has anticoagulant cofactor activity for the protein C pathway", "year": "1997"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-6RzNnnwWf8C", "citedby": "0"}, {"bib": {"title": "Potent blood coagulant activity of human semen due to prostasome-bound tissue factor.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wyM6WWKXmoIC", "citedby": "0"}, {"bib": {"title": "Protein C pathway is upregulated at birth by multiple mechanisms compensating for low protein C level.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YPNY0knpFBYC", "citedby": "0"}, {"bib": {"title": "Total chemical synthesis of active human platelet phospholipase A (2) that inhibits prothrombinase activity in a phospholipid independent way.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_AeoHAGD03cC", "citedby": "0"}, {"bib": {"title": "Purification and inhibition of oxidosqualene-lanosterol cyclase.", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:h168fVGZblEC", "citedby": "0"}, {"bib": {"title": "Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods", "year": "1996"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hHIA4WEVY-EC", "citedby": "0"}, {"bib": {"title": "Protein C inhibitor (PAI-3) in human pancreas.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:bXQfdp6S9ecC", "citedby": "0"}, {"bib": {"title": "Influence of carbohydrate moieties of factor V (FV) on APC resistance.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:txeM2kYbVNMC", "citedby": "0"}, {"bib": {"title": "Inhibition of protein C activation by antiphospholipid antibodies in vitro is dependent on the composition of phospholipid (PL) liposomes used as template.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RuPIJ_LgqDgC", "citedby": "0"}, {"bib": {"title": "Factor Va (FVa) heavy chain peptide VP493 inhibits both FVa activity and activated protein C (APC) inactivation of FVa.", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:H_jBuBxbQIAC", "citedby": "0"}, {"bib": {"title": "ACTIVATED PROTEIN-C (APC) RESISTANCE-MOLECULAR MECHANISMS BASED ON STUDIES USING PURIFIED GLN (506)-FACTOR-V", "year": "1995"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QaSi33NTfwYC", "citedby": "0"}, {"bib": {"title": "A PROTHROMBIN TIME-BASED ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANT FACTOR-V (FV) IN PATIENTS ON WARFARIN OR WITH A LUPUS ANTICOAGULANT", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:aDl3D7KC1E4C", "citedby": "0"}, {"bib": {"title": "INTRACELLULAR PROTEIN-C INHIBITOR-ELECTRON-MICROSCOPIC LOCALIZATION IN LYSOSOMES OF HUMAN KIDNEY", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PuOEWVtPfzwC", "citedby": "0"}, {"bib": {"title": "MECHANISM OF RESISTANCE TO ACTIVATED PROTEIN-C (APC)", "year": "1994"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:R22Rs3tN8aoC", "citedby": "0"}, {"bib": {"title": "INHIBITION OF PLASMINOGEN ACTIVATOR-DEPENDENT CLOT LYSIS BY THROMBOMODULIN", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:vnF2_uLGgtgC", "citedby": "0"}, {"bib": {"title": "GENERATION OF BOTH PLASMIN AND ACTIVATED PROTEIN-C DURING THROMBOLYTIC THERAPY WITH STREPTOKINASE", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g8uWPOAv7ggC", "citedby": "0"}, {"bib": {"title": "DEFECTIVE ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C (APC) IS COMMON IN VENOUS THROMBOPHILIA AND CORRECTED BY A NOVEL ANTICOAGULANT PLASMA FACTOR", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:hNSvKAmkeYkC", "citedby": "0"}, {"bib": {"title": "EVIDENCE FOR THE PHYSIOLOGICAL REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN, URINE AND BLOOD", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:uAPFzskPt0AC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF A SEQUENCE IN THE LIGHT-CHAIN OF HUMAN ACTIVATED PROTEIN-C (RESIDUES-142-155) ESSENTIAL FOR ITS INTERACTION WITH FACTOR-VA", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BJtnxTr0fRcC", "citedby": "0"}, {"bib": {"title": "PROTEIN-S IS ANTICOAGULANT IN THE ABSENCE OF ACTIVATED PROTEIN-C (APC)", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:E7VqQtBCVmcC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF A MONOCLONAL ANTI-C4B BINDING-PROTEIN BETA-CHAIN ANTIBODY EPITOPE NEAR THE PROTEIN-S BINDING-SITE", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:I8rxH6phXEkC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION AND CHARACTERIZATION OF A PROTEIN-S BINDING-SITE IN THE BETA-CHAIN OF C4B-BINDING PROTEIN USING SYNTHETIC PEPTIDES AND COMPUTER-GRAPHICS HOMOLOGY MODELING", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ymY9cBF3mdcC", "citedby": "0"}, {"bib": {"title": "GENERATION OF ACTIVATED PROTEIN-C DURING CORONARY THROMBOLYSIS IN PATIENTS WITH MYOCARDIAL-INFARCTION", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ijdKiLOsEJMC", "citedby": "0"}, {"bib": {"title": "EXPRESSION AND LOCALIZATION OF THE SERPIN PROTEIN-C INHIBITOR (PAI-3) IN HUMAN AND RHESUS-MONKEY KIDNEY", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AzKEL7Gb_04C", "citedby": "0"}, {"bib": {"title": "PROTEIN-C INHIBITOR (PAI-3)-AN ALLELIC POLYMORPHISM WITH DIFFERENT FREQUENCIES IN DIFFERENT ETHNIC-GROUPS", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-yGd096yOn8C", "citedby": "0"}, {"bib": {"title": "3-DIMENSIONAL STRUCTURE PREDICTION OF THE PROSTATE-CANCER MARKER, PROSTATE-SPECIFIC ANTIGEN", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:pYKElYtJMmwC", "citedby": "0"}, {"bib": {"title": "Concordance rates ofinsulin dependent diabetes mellitus: a population based study ofyoung Danish twins", "year": "1993"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:s2G-WRnXBicC", "citedby": "0"}, {"bib": {"title": "PROTEIN-S BINDS TO BETA-CHAIN (30-45) IN C4B-BINDING PROTEIN", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8VtEwCQfWZkC", "citedby": "0"}, {"bib": {"title": "PROTEIN-C INHIBITOR IN RHESUS-MONKEY PLASMA", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BAanoTsO0WEC", "citedby": "0"}, {"bib": {"title": "PROTEIN-S BINDS TO FACTOR VA AND CAN DIRECTLY INHIBIT PROTHROMBINASE INDEPENDENT OF ACTIVATED PROTEIN-C", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:7Frjd3zlGBUC", "citedby": "0"}, {"bib": {"title": "Induced anticoagulant therapy by endogenous activated protein C (APC)", "year": "1992"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BOlwja0KXvYC", "citedby": "0"}, {"bib": {"title": "PROTEIN-C INHIBITOR", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TGkaJS32XoUC", "citedby": "0"}, {"bib": {"title": "INACTIVATION OF HUMAN FACTOR VA BY ACTIVATED PROTEIN-C-CORRELATION OF THE KINETICS OF INACTIVATION WITH STRUCTURAL-CHANGES OF FACTOR VA", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6ZzL7HXColQC", "citedby": "0"}, {"bib": {"title": "ACTIVATION OF THE PROTEIN-C PATHWAY DURING ACUTE VASCULAR DAMAGE INDUCED BY MEDITERRANEAN SPOTTED-FEVER", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QsKbpXNoaWkC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF REGIONS OF ACTIVATED PROTEIN-C (APC) ESSENTIAL FOR ANTICOAGULANT ACTIVITY", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:PQEM9vzQD9gC", "citedby": "0"}, {"bib": {"title": "VITRONECTIN DOES NOT ENHANCE THROMBIN OR ACTIVATED PROTEIN-C INHIBITION BY PAI-1", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:iyewoVqAXLQC", "citedby": "0"}, {"bib": {"title": "QUANTITATION OF CIRCULATING ACTIVATED PROTEIN-C (APC) IN HUMANS", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:BJrgspguQaEC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF ALPHA-MACROGLOBULIN (ALPHA-2-M) AND ALPHA-ANTIPLASMIN (ALPHA-2-AP) AS CA++-DEPENDENT PHYSIOLOGICAL INHIBITORS OF ACTIVATED PROTEIN C (APC)", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:G1UMdFYMoxkC", "citedby": "0"}, {"bib": {"title": "COMPARISON OF PROCOAGULANT AND ANTICOAGULANT ACTIVITIES OF PLATELETS AND PLATELET-DERIVED MICROPARTICLES", "year": "1991"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0aBXIfxlw9sC", "citedby": "0"}, {"bib": {"title": "THE N-TERMINAL REGION OF PROTEIN-C INHIBITOR (PCI) IS INVOLVED IN HEPARIN BINDING", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:QoJ_w57xiyAC", "citedby": "0"}, {"bib": {"title": "REGULATION OF ACTIVATED PROTEIN-C (APC) BY 4 INHIBITORS INVIVO IN BABOONS", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:LK8CI43ZvvMC", "citedby": "0"}, {"bib": {"title": "Increased levels of complexes of activated protein C with \u03b11-antitrypsin in normal pregnancy and in preeclampsia", "year": "1990"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:TesyEGJKHF4C", "citedby": "0"}, {"bib": {"title": "INACTIVATION OF HUMAN FACTOR-VA BY ACTIVATED PROTEIN-C (APC)", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qsWQJNntlusC", "citedby": "0"}, {"bib": {"title": "PROTEIN-C INHIBITOR AND ITS COMPLEXES IN NORMAL PREGNANT AND PREECLAMPTIC PREGNANT PLASMA", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qmtmRrLr0tkC", "citedby": "0"}, {"bib": {"title": "Activated protein C is anticoagulant because it is a potent", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-uzm3Y7AvW0C", "citedby": "0"}, {"bib": {"title": "Deficiencies of Protein C and Protein S and Thromoembolic Disease", "year": "1989"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:J3LtWjKFLicC", "citedby": "0"}, {"bib": {"title": "COMPLEXATION OF ACTIVATED PROTEIN-C (APC) WITH 2 PHYSIOLOGIC PLASMA INHIBITORS", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SxCCDk4iOpsC", "citedby": "0"}, {"bib": {"title": "ALPHA-1-ANTITRYPSIN IS A PHYSIOLOGIC INHIBITOR OF HUMAN ACTIVATED PROTEIN-C (APC)", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:YB4bud6kWLwC", "citedby": "0"}, {"bib": {"title": "2 PHYSIOLOGIC INHIBITORS OF ACTIVATED PROTEIN-C (APC)", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:8dzOF9BpDQoC", "citedby": "0"}, {"bib": {"title": "FD RESEARCH COMMUNICATIONS", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lRPiJ3GhvscC", "citedby": "0"}, {"bib": {"title": "Protein C and Protein S Defects in Thromboembolic Disease JH Griffin Department of Immunology, Research Institute of Scripps Clinic, La JoUa, California, USA.", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rzmi0EmCOGEC", "citedby": "0"}, {"bib": {"title": "53 Mechanisms of intrinsic fibrinolysis: Neutralization of type 1 plasminogen activator inhibitor by the enzymes of the contact system", "year": "1988"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:s9ia6_kGH2AC", "citedby": "0"}, {"bib": {"title": "DETECTION AND QUANTITATION OF CLEAVED AND UNCLEAVED HIGH-MOLECULAR-WEIGHT KININOGEN IN PLASMA BY LIGAND BLOTTING WITH RADIOLABELED PLASMA PREKALLIKREIN OR FACTOR-XI", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ghEM2AJqZyQC", "citedby": "0"}, {"bib": {"title": "PROTEIN C IS ACTIVATED AND GIVES 110,000 MW COMPLEXES AND PROTEIN S IS CLEAVED AND DECREASED _IN VIVO IN PATIENTS WITH INTRAVASCULAR COAGULATION (DIC)", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:xii_ZKWM4-0C", "citedby": "0"}, {"bib": {"title": "ISOLATION AND FUNCTIONAL PROPERTIES OF MONOMERIC BLOOD COAGULATION FACTOR XI", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:XAp-VaTZjjwC", "citedby": "0"}, {"bib": {"title": "APPLICATION OF SPECIFIC SERINE PROTEASE INHIBITORS IN ASSAYS FOR ACTIVATED CONTACT FACTORS.", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ic1VZgkJnDsC", "citedby": "0"}, {"bib": {"title": "MEASUREMENT OF SPLIT AND NATIVE HIGH-MOLECULAR-WEIGHT KININOGEN IN PLASMA USING LIGAND BLOTTING TECHNIQUE", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:V_vSwabWVtYC", "citedby": "0"}, {"bib": {"title": "XITH CONGRESS OF THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS", "year": "1987"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:zUl2_INMlC4C", "citedby": "0"}, {"bib": {"title": "ACTIVATED PROTEIN-C (APC) COMPLEXES WITH HUMAN-PLATELET PLASMINOGEN-ACTIVATOR (PA) INHIBITOR (PAI)", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:eGYfIraVYiQC", "citedby": "0"}, {"bib": {"title": "DECREASED LEVELS OF PROTEIN-C AND PROTEIN-S IN INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM)", "year": "1986"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:as0KMg8qHbkC", "citedby": "0"}, {"bib": {"title": "KINETIC-ANALYSIS OF SURFACE-DEPENDENT FACTOR-XII ACTIVATION BY KALLIKREIN AND ITS ISOLATED LIGHT CHAIN", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:0ngZmJvimKcC", "citedby": "0"}, {"bib": {"title": "PROTEIN-C AND PROTEIN-S IN THROMBOTIC DISEASE", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:60iIaj97TE0C", "citedby": "0"}, {"bib": {"title": "FAMILIAL THROMBOTIC DISEASE DUE TO PLASMA PROTEIN-S DEFICIENCY", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:AZju0d2GQJ0C", "citedby": "0"}, {"bib": {"title": "QUANTITATIVE WESTERN IMMUNOBLOTTING TECHNIQUE FOR THE STUDY OF FACTOR-XII (XII) IN WHOLE PLASMA", "year": "1985"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:RJOyoaXV5v8C", "citedby": "0"}, {"bib": {"title": "Overview on Blood Coagulation Proteins", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JH5k92_tO-AC", "citedby": "0"}, {"bib": {"title": "COORDINATE ZN++ AND CA++ ION-DEPENDENT BINDING OF HIGH MW KININOGEN AND FACTOR-XI TO PLATELETS", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:cBPnxVikjH8C", "citedby": "0"}, {"bib": {"title": "CLEAVAGE OF HUMAN COAGULATION FACTOR-IX BY FACTOR-XIA AND FACTOR-XIA LIGHT CHAIN", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:9DLIHnF0jcYC", "citedby": "0"}, {"bib": {"title": "PROTEIN-S, A PROTEIN-C COFACTOR, IN WASHED HUMAN-PLATELETS", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Zh0EY9V9P6UC", "citedby": "0"}, {"bib": {"title": "PROTEIN-C-DEPENDENT FIBRINOLYTIC-ACTIVITY OF CULTURED BOVINE AND HUMAN-ENDOTHELIAL CELLS", "year": "1984"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:C33y2ycGS3YC", "citedby": "0"}, {"bib": {"title": "COMPARISON OF THE EFFICACY OF THE NEWER COAGULATION TESTS USING ROC CURVES", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:yJjnfzR0HrkC", "citedby": "0"}, {"bib": {"title": "Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen.", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Vno172sVVMwC", "citedby": "0"}, {"bib": {"title": "Immunochemical studies of human kininogen.", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ndLnGcHYRF0C", "citedby": "0"}, {"bib": {"title": "ISOLATION AND FUNCTIONAL-CHARACTERIZATION OF THE HEAVY AND LIGHT-CHAINS OF HUMAN-PLASMA KALLIKREIN AND ACTIVATED FACTOR-XI", "year": "1983"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lg2tdxc6qMwC", "citedby": "0"}, {"bib": {"title": "IMMUNOLOGICAL STUDIES OF HUMAN FACTOR-XI AND PREKALLIKREIN-DEMONSTRATION OF COMPLEX-FORMATION WITH HIGH MW KININOGEN", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:6VlyvFCUEfcC", "citedby": "0"}, {"bib": {"title": "ISOLATION AND PROPERTIES OF THE HEAVY AND LIGHT-CHAINS OF PREKALLIKREIN", "year": "1982"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:n3vGvpFsckwC", "citedby": "0"}, {"bib": {"title": "IN CONTACT ACTIVATION", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:jtI9f0ekYq0C", "citedby": "0"}, {"bib": {"title": "ALTERNATIVE PATHWAYS OF THROMBOPLASTIN-DEPENDENT ACrIVATION", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:isU91gLudPYC", "citedby": "0"}, {"bib": {"title": "EFFECT OF 2 SOLUBLE ACTIVATORS ON THE ACTIVITY OF FACTOR-XII AND FACTOR-XIIA (HAGEMAN-FACTOR)", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:-vzq6BoH5oUC", "citedby": "0"}, {"bib": {"title": "Effect Of Two Soluble", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:lK9BDNCuzFgC", "citedby": "0"}, {"bib": {"title": "PROTEINS IN CONTACT ACTIVATION", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:sbeIDTyQOFgC", "citedby": "0"}, {"bib": {"title": "Dextran Sulfate Stimulated Fibrinolytic Activity In Whole Human Plasma: Dependence On The Contact Activation System And On 4 Urokinase-Related Antigen", "year": "1981"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "THE ELLAGIC ACID-DEPENDENT ACTIVATION OF FACTOR XI BY FACTOR XII", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rCNdntzdTkkC", "citedby": "0"}, {"bib": {"title": "IMMUNOLOGICAL STUDIES OF BIMOLECULAR COMPLEXES OF PREKALLIKREIN OR KALLIKREIN AND HIGH MW KININOGEN OR ITS LIGHT CHAIN", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wUn16MOA3RoC", "citedby": "0"}, {"bib": {"title": "NEW ANTIGEN RELATED TO COAGULATION-FACTOR IX DEMONSTRATED BY ISOELECTRIC-FOCUSING OF PLASMA", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:2vr6o8x5NLkC", "citedby": "0"}, {"bib": {"title": "STUDIES OF THE INHIBITION OF CLS (-), KALLIKREIN, AND ACTIVATED HAGEMAN-FACTOR (HF) BY FUNCTIONAL AND NONFUNCTIONAL CL INHIBITORS FROM A PATIENT WITH ANGIOEDEMA", "year": "1980"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:MIg0yeAD4ggC", "citedby": "0"}, {"bib": {"title": "Mechanisms of Human Blood VII Activation in Plasma During Contact Activation, Clotting and Exposure to Cold", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Ei5r6KrKXVQC", "citedby": "0"}, {"bib": {"title": "DFP (Dilsopropylfluorophosphate) Studies on Molecular Mechanisms of Surface-Dependent Activation of Prekallikrein (PK) and Factor XII (Hageman Factor, HF)", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:s1ouQE5r0WUC", "citedby": "0"}, {"bib": {"title": "Hageman Factor (HF, Factor XII)-Dependent Activation of Coagulation, Kinin-Forming, and Fibrinolytic Pathways by Surface Contact", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:1paMEeroeoQC", "citedby": "0"}, {"bib": {"title": "INHIBITION OF THE ACTIVITY OF ALPHA-2-PLASMIN INHIBITOR BY THE SYNTHETIC FIBRINOLYTIC AGENT, 3-HYDROXYPROPYL FLUFENAMIDE", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:i_7YvbSbtFEC", "citedby": "0"}, {"bib": {"title": "MECHANISM OF ACTIVATION OF PREKALLIKREIN", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:rbGdIwl2e6cC", "citedby": "0"}, {"bib": {"title": "Inflammation, a Role of the Hageman Factor System", "year": "1979"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oPLKW5k6eA4C", "citedby": "0"}, {"bib": {"title": "Structure-function relationships of human high MW kininogen related to contact activation of plasma.", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WzTVkKNmPSkC", "citedby": "0"}, {"bib": {"title": "RABBIT FACTOR-XI-PURIFICATION, PROPERTIES AND MECHANISM OF ACTIVATION BY RABBIT FACTOR-XIIA", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:g_UdREhPGEoC", "citedby": "0"}, {"bib": {"title": "ASSESSMENT OF CURRENT MODEL OF BLOOD-COAGULATION PATHWAYS", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EaFouW7jFu4C", "citedby": "0"}, {"bib": {"title": "BLOOD COAGULATION FACTOR XI", "year": "1978"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:qE4H1tSSYIIC", "citedby": "0"}, {"bib": {"title": "Carbon-13 [isotope] nuclear magnetic resonance studies of the binding of selectivity 13 C-enriched oxytocins to the nuerohypophyseal protein, bovine neurophysin II", "year": "1977"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:WwIwg2wKZ0QC", "citedby": "0"}, {"bib": {"title": "ESSENTIAL PROTEINS FOR CONTACT ACTIVATION OF HAGEMAN-FACTOR PATHWAYS", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:l6Q3WhenKVUC", "citedby": "0"}, {"bib": {"title": "HUMAN FACTOR-11-PURIFICATION, PROPERTIES AND MECHANISM OF ACTIVATION BY FACTOR-12-ALPHA", "year": "1976"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NxmKEeNBbOMC", "citedby": "0"}, {"bib": {"title": "STUDIES ON ACTIVATION OF HUMAN-BLOOD COAGULATION-FACTOR XII (HAGEMAN-FACTOR)", "year": "1975"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:j5aT6aphRxQC", "citedby": "0"}, {"bib": {"title": "PHYSICOCHEMICAL STUDIES OF BOVINE NEUROPHYSINS-NEUROHYPOPHYSEAL HORMONES INTERACTIONS", "year": "1974"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:nWoA1JPTheMC", "citedby": "0"}, {"bib": {"title": "NMR PARAMAGNETIC RELAXATION STUDIES OF A SUBSTRATE ANALOG BOUND TO STAPHYLOCOCCAL NUCLEASE", "year": "1974"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:SrKkpNFED5gC", "citedby": "0"}, {"bib": {"title": "Studi sul cromoforo nitrotirosinico nella nucleasi di stafilococco aureo ed in una dichetopiperazina modello", "year": "1974"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:37UQlXuwjP4C", "citedby": "0"}, {"bib": {"title": "NMR-STUDIES OF BOVINE PANCREATIC RIBONUCLEASE-DINUCLEOTIDE PHOSPHONATE COMPLEX", "year": "1973"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:4Yq6kJLCcecC", "citedby": "0"}, {"bib": {"title": "LACTIC DEHYDROGENASE-NAD-PYRUVATE TERNARY COMPLEX FORMATION: REACTION MECHANISM AND ESSENTIAL ROLE OF SUBUNIT INTERACTIONS.", "year": "1971"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:NZNkWSpQBv0C", "citedby": "0"}, {"bib": {"title": "COVID\u201019 Hypothesis: Activated Protein C for Therapy of Virus\u2010induced Pathologic Thromboinflammation"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:onKP9CxGSkIC", "citedby": "0"}, {"bib": {"title": "Effect of hyperhomocysteinemia on protein C activation and activity"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:E8ajGqO0XoUC", "citedby": "0"}, {"bib": {"title": "Pharmacological targeting of the thrombomodulin\u2013protein C pathway mitigates radiation toxicity"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:_IsBomjs8bsC", "citedby": "0"}, {"bib": {"title": "Department of Molecular Medicine"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:oynPyU19kbsC", "citedby": "0"}, {"bib": {"title": "Supplemental Information for Publication"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:gmHTDCtJMcoC", "citedby": "0"}, {"bib": {"title": "Low Total Protein S Antigen but High Protein S Activity due to Decreased C4b-Binding Protein in Neonates"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:wGzT3bKASkAC", "citedby": "0"}, {"bib": {"title": "Molecular and Experimental Medicine"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:c1AJUTjuCtUC", "citedby": "0"}, {"bib": {"title": "Influence of the 3K3A-\u2010activated protein C variant on the in vitro fibrinolytic activity of tPA"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:EBV337fEn3EC", "citedby": "0"}, {"bib": {"title": "Other Classes"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:Y0-TYkg6YM4C", "citedby": "0"}, {"bib": {"title": "Molecular and Experimental Medicine"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:ji7lAbPyDbYC", "citedby": "0"}, {"bib": {"title": "165 Glucocorticoids act on glutamatergic pathways to affect memory processes"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JWITY9-sCbMC", "citedby": "0"}, {"bib": {"title": "Regulation of coagulation by the antithrombotic protein C pathway"}, "source": "citations", "id_citations": "srdc_BYAAAAJ:JP7YXuLIOvAC", "citedby": "0"}]}